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ZUSAMMENFASSUNG
Zellen enthalten ein komplexes System aus Filamenten, das Zytoskelett, welches eine Vielzahl von zellulären Prozessen 
reguliert.   In  Säugerzellen unterscheidet  man  drei  Arten  dieser  Filamente:  Aktinfilamente,  Mikrotubuli  und 
Intermediärfilamente.  Diese  Arbeit  beschäftigt  sich  hauptsächlich  mit  Aktinfilamenten  und Regulatorproteinen,  welche 
hauptsächlich an der Plasmamembran lokalisiert sind und die Morphologie der Zelle maßgeblich beeinflussen.
Zunächst  wurde  der  Einfluss  von niedermolekularen  Wirkstoffen,  welche  aus  Naturstoffen  abgeleitet  wurden,  auf  das 
dynamische  Aktin-Netzwerk  untersucht.  Für  einen  dieser  Wirkstoffe  (LGM235)  konnte  selbst  bei  sehr  geringen 
Konzentrationen (~85 pM) gezeigt werden, dass er einen Einfluss auf die Organisation von Aktin in Zellen hat. Aus dieser  
Substanz wurde ein fluoreszenzmarkiertes Analogon entwickelt, welches zellpermeabel und nicht-toxisch ist, um statische 
Aktinstrukturen in lebenden Zellen zu untersuchen.
Darüber hinaus wurden in dieser Arbeit eine Reihe von Biosensoren entwickelt, um die Aktivität von Signalmolekülen aus  
der Familie der Rho-GTPasen (Rac1, Cdc42 und RhoA) zu messen. Diese Signalmoleküle regulieren hauptsächlich das 
Aktin  Zytoskelett.  Aktivitätsmessungen  mit  diesen  Biosensoren  wurden  mit  Aktivitätsstörungen  durch  ein 
photoaktivierbares Rac1-Konstrukt kombiniert,  um die gegenseitige Regulation der Proteine Rac1, Cdc42 und RhoA zu 
charakterisieren. Überraschenderweise konnte gezeigt werden, dass als Antwort auf eine akute Photoaktivierung von Rac1 
die Aktivität von Rac1, Cdc42 und RhoA erhöht wurde. Es wurde jedoch eine unerwartete subzelluläre Lokalisation von 
photoaktivierbarem Rac1  beobachtet,  welche  die  Messung  der  gegenseitige  Regulation  der  Rho  GTPasen  erschweren 
könnte.  Daher  wurde  ebenfalls  ein  optimiertes  photoaktivierbares  Rac1-Konstrukt  entwickelt,  in  welchem  diese 
Mislokalisation unterdrückt wurde.
Alternativ  zur  Photoaktivierung  wurde  eine  neue,  generelle  Methode  zur  Kontrolle  der  Aktivität  von  Rho  GTPasen 
basierend  auf  chemisch  induzierter  Dimerisierung  (CID)  entwickelt.  Bei  diesem  Ansatz  bindet  ein  niedermolekularer 
Wirkstoff („Dimerizer“) gleichzeitig zwei Proteindomänen und bildet so einen heterodimeren Proteinkomplex. Da keine der 
beiden  Proteindomänen  natürlicherweise  in  Säugerzellen  vorkommt,  handelt  es  sich  hierbei  um  einen  neuartigen,  
bioorthogonalen  CID-Ansatz,  der  zur  Kontrolle  der  Proteinfunktion  genutzt  werden  kann.  Die  C-terminale 
Aminosäuresequenz von K-Ras wurde an eine dieser Domänen fusioniert, um eine Lokalisation an der Plasmamembran zu 
gewährleisten. Eine dauerhaft aktive Mutante von Rac1 wurde an die andere der beiden Domänen fusioniert. Zusätzlich 
wurde die Plasmamembran Lokalisationssequenz von Rac1 entfernt, sodass sich dieses Konstrukt im Zytoplasma befindet. 
Kurz  nach  Zugabe des  Dimerizers  auf  Zellen,  welche  beide  Fusionsproteine  synthetisieren,  konnte  eine  sehr  schnelle 
Rekrutierung des Fusionsproteins mit der Rac1-Mutante zur Plasmamembran beobachtet werden. Diese Rekrutierung löste 
die Entstehung von Rac1-typischen Aktin-Fortsätzen an den Rändern der Zelle aus. Analoge Experimente mit dauerhaft 
aktiven  Cdc42-  und RhoA-Mutanten induzierten ebenfalls  Änderungen im Aktin-Zytoskelett  und der  Zellmorphologie, 
welche charakteristisch für diese Signalproteine sind.
Die in dieser Arbeit entwickelten Werkzeuge können genutzt  werden, um die Dynamik von Aktinstrukturen und deren 
Regulation durch Signalnetzwerke der Rho GTPasen zu untersuchen.
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ABSTRACT
Cells contain a complex system of filaments called the cytoskeleton that regulates a variety of cellular processes.  In 
mammalian cells, these filaments can be categorized into three groups: actin filaments, microtubules and intermediate 
filaments. The work presented here focuses on actin filaments, which are predominantly found beneath the plasma 
membrane, where they play a central role in determining cell shape.
First, small molecules based on natural products were screened for their ability to perturb actin dynamics.  One of 
these molecules (LGM235) was shown to influence the organization of actin in cells, even at extremely low 
concentrations (~85 pM).  A fluorescently labeled analogue of LGM235 was found to be cell permeable and non-
toxic, making it useful in studying static actin within living cells.
Next, a series of biosensors was developed in order to study the activities of three members (Rac1, Cdc42, and RhoA) 
of the Rho GTPase family of signaling molecules that are known to regulate the actin cytoskeleton.  These biosensors 
were tested in combination with a photoactivatable Rac1 (PA-Rac1) construct to study the crosstalk between Rac1, 
Cdc42, and RhoA.  Surprisingly, these experiments showed that the activities of Rac1, Cdc42, and RhoA all increase 
in response to acute photoactivation of Rac1. However, PA-Rac1 displayed an unexpected subcellular localization that 
is inconsistent with that of wild-type or constitutively active Rac1, making these crosstalk measurements difficult to 
interpret. Therefore, an optimized photoactivatable Rac1 construct was developed that localizes primarily to the 
plasma membrane.
As an alternative to photoactivation, a new and more generally applicable method of controlling Rho GTPase activity, 
based on chemically induced dimerization (CID), was developed.  In this approach, a small molecule (referred to as a 
“dimerizer”) binds simultaneously to two distinct protein modules to form a heterodimeric protein complex. Because 
neither of the protein modules described here are endogenous to mammalian cells, this approach represents a novel 
bioorthogonal CID system that can be used to control protein function in cells.  The C-terminal sequence from K-Ras 
was fused to one of these modules to ensure that it would localize to the plasma membrane.  A constitutively active 
mutant of Rac1 lacking a prenylation site was fused to the other protein module and was observed largely in the 
cytosol.  When dimerizer was added to cells expressing these two proteins, rapid recruitment of the constitutively 
active Rac1 mutant to the plasma membrane was observed.  This recruitment, was accompanied by the formation of 
actin-based protrusions at the cell periphery that are typically observed upon activation of Rac1.  And, similar 
experiments with constitutively active Cdc42 and RhoA mutants produced changes in the actin cytoskeleton and in 
cell morphology that are consistent with activation of these signaling molecules.
The tools described here can be used to study actin dynamics and its regulation by Rho GTPase signaling networks.
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1. INTRODUCTION
The human body is composed of a variety of cell types that perform a multitude of tasks.  Frequently, 
the shape of a particular cell plays an important role in its function.  For example, in the small intestine, 
epithelial cells form protrusions called microvilli near the apical surface that help them to absorb 
nutrients from digested food (Fig. 1.1A)1.  Similarly, hair cells within the inner ear also form 
protrusions called stereocilia that allow these cells to sense forces (Fig. 1.1B)1 .  Improper stereocilia 
formation can lead to deafness1.  In the brain, neurons can also form protrusions called growth cones 
that help to guide these cells as they grow and develop (Fig. 1.1C)2.  In all of these examples, actin 
filaments play a central role in determining the shapes of the protrusions.
A B
C
Figure 1.1:  Examples of Cells that Form Actin-based Protrusions.  (A) Epithelial cells in the 
small intestine form actin-based protrusions called microvilli.  These protrusions increase the 
surface areas of the cells, making it easier for them to absorb nutrients from digested food as it 
passes by. (B)  Hair cells within the inner ear also form protrusions called stereocilia that allow 
these cells to sense forces.  If these stereocilia are improperly formed, this can lead to deafness.
(C) Neurons can also form protrusions called growth cones that help to guide these cells as they 
migrate.  (These figures were taken from references 1-3).
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In mammalian cells, the complex system of actin filaments, intermediate filaments, and microtubules is 
referred to as the cytoskeleton.
1.1 Actin Can Rapidly Convert Between Monomeric and Filamentous 
Forms
Actin filaments are often referred to as polymers. However, this term can be misleading. Unlike other 
biological polymers (such as DNA, RNA, proteins, and polysaccharides) the subunits of actin filaments 
are not covalently bonded to each other.  Rather, these subunits are held together by weak noncovalent 
forces. This makes it possible for actin subunits to rapidly convert between monomeric and filamentous 
forms (Fig. 1.2).  The assembly and disassembly of actin filaments is also regulated by many accessory 
proteins.
Figure 1.2:  Actin Can Rapidly Convert Between Monomeric and Filamentous Forms.  (A) 
Structure of an actin subunit.  (B). Cartoon demonstrating how a cell can respond to an external 
stimulus by rapidly rearranging its actin cytoskeleton.  (These figures were taken from reference 3).
Nucleators are a group of accessory proteins that promote filament assembly.  As their name suggests, 
nucleators function by assembling actin subunits into a “nucleus”.  Formation of an actin nucleus is the 
rate limiting step in filament assembly and proceeds slowly in the absence of a nucleator3.    Once a 
nucleus of actin filaments has formed, additional actin subunits can quickly bind to and elongate this 
structure.
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Formins are a group of actin nucleators that promote the formation of linear filaments.  These enzymes 
form dimers that can accommodate two actin subunits.  When both of these binding sites are filled, the 
formin dimer undergoes a conformational change that allows it to release one of the actin subunits and 
expose a new binding site while it remains anchored to the other subunit.  A repetitive cycle of actin 
subunit binding followed by structural rearrangement of the formin dimer leads to nucleation and 
elongation of an actin filament (Fig. 1.3a).  These actin filaments can be crosslinked by other accessory 
proteins to produce actin bundles such as those observed in microvilli, stereocilia, and filopodia (Fig. 
1.1).
Figure 1.3:  Actin Nucleation by Formins and the Arp2/3 Complex.  (a) Formins promote the 
formation of linear filaments.  These enzymes form dimers that can accommodate two actin 
subunits.  When both of these binding sites are filled, the formin dimer undergoes a conformational 
change that allows it to release one of the actin subunits and expose a new binding site while it 
remains anchored to the other subunit. A repetitive cycle of actin subunit binding followed by 
structural rearrangement of the formin dimer leads to nucleation and elongation of an actin 
filament.  (b) The Arp2/3 complex promotes the formation of a branched network of actin 
filaments.  The Arp2/3 complex consists of seven proteins, including two Actin-Related Proteins 
(Arp2 and Arp3) that share significant sequence and structural similarities with actin.  The Arp2/3 
complex can bind to the side of an existing actin filament and promote the formation of a new 
filament that forms a 70° angle to the original filament. (These figures were taken from reference 
2).
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Actin filaments can also be nucleated by a group of proteins known as the Arp2/3 complex.  This 
complex consists of seven proteins, including two Actin-Related Proteins (Arp2 and Arp3) that share 
significant sequence and structural similarities with actin.  The Arp2/3 complex can bind to the side of 
an existing actin filament and promote the formation of a new filament that forms a 70° angle to the 
original filament (Fig. 1.3b).  This branched network of actin filaments can lead to large-scale 
structures such as lamellipodia (Fig. 1.1C).
The Arp2/3 complex is highly concentrated at the leading edge of keratocyte cells (Fig. 1.4A, top)4, 
where it can promote the assembly of actin filaments (Fig. 1.4A, middle) that push against the plasma 
membrane at the leading edge of these motile cells.  This protrusive force appears to operate in 
conjunction with other forces to move cells in a particular direction (Fig. 1.4B).  For example, while 
actin assembly stretches the cell at the leading edge, motor proteins (e.g., myosin II) provide a 
constrictive force at the trailing edge to prevent tension from building up within the cell.  Similarly, 
loss of contacts between the cell and the substratum at the trailing edge is balanced by the formation of 
new contacts at the leading edge.
A B
Figure 1.4:  The Role of Actin Polymerization in Cell Motility.  (A) A keratocyte was fixed, 
permeablized, and stained to show the localization of the Arp2/3 complex and actin within this 
motile cell.  The Arp2/3 complex was stained using antibodies while actin was stained with a 
fluorescently-labeled phalloidin.  (B) This image shows a model of the forces involved in cell 
motility.  As newly formed actin filaments push against the plasma membrane at one end of the 
cell, motor proteins (e.g., myosin II) provide a constrictive force at the opposite end of the cell to 
prevent tension from building up within the cell.  Similarly, loss of contacts between the cell and 
the substratum at the trailing edge is balanced by the formation of new contacts at the leading 
edge. (These figures were taken from references 3-4).
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Interestingly, small molecules that disrupt actin dynamics have been isolated from various natural 
sources (Table 1.1)3,5-8.  These natural products can be used as tools to study the actin cytoskeleton.  For 
example, fluorescently labeled phalloidins are frequently used to stain actin filaments in fixed and 
permeabilized cells (Fig. 1.4A, middle).  Alternatively, these natural products can be used as templates 
to develop new tools to study actin dynamics5,8.
Table 1.1: Small Molecules That Interfere With Actin Dynamics
Small Molecule Interferes With Actin Dynamics by ... Isolated From
phalloidin binding to and stabilizing filaments Amanita phalloides(death cap mushroom)
jasplakinolide binding to and stabilizing filaments Jaspis splendans(sea sponge)
chondramide C binding to and stabilizing filaments Chondromyces crocatus(myxobacterium)
cytochalasin capping filament plus ends
Helminthosporium 
dematioideum
(mold)
swinholide severing filaments Theonella swinhoei(sea sponge)
latrunculin binding to subunits and preventing their assembly into filaments
Latrunculia magnifica
(sea sponge)
1.2 Rho GTPases are Signaling Molecules that Influence Actin 
Dynamics
Extensive studies have shown that Rho GTPases play a central role in coordinating actin dynamics in 
cells.  For example, Hall et al. showed that selective activation of RhoA, Rac1, or Cdc42 led to distinct 
rearrangements in the actin cytoskeletons of serum-starved Swiss 3T3 cells (Fig. 1.5)9.   Activation of 
RhoA led to the formation of stress fibers (Fig. 1.5B) while activation of Rac1 or Cdc42 led to the 
formation of actin-based protrusions at the cell periphery; lamellopodia were formed in response to 
activation of Rac1 (Fig. 1.5C) and filopodia were formed in response to activation of Cdc42 (Fig. 
1.5D).
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Figure 1.5:  Selective Activation of RhoA, Rac1, or Cdc42 Produces Distinct Rearrangements 
in the Actin Cytoskeletons of Serum-Starved Swiss 3T3 Cells.   For each of the conditions, actin 
was stained with rhodamine-labeled phalloidin.  (A) A control serum-starved cell.  (B) A cell that 
produced stress fibers in response to activation of RhoA.  (C) A cell that produced a lamellipodium 
in response to activation of Rac1.  (D) A cell that produced filopodia in response to activation of 
Cdc42.  (These figures were taken from reference 3).
However, although these three Rho GTPases can induce rearrangements in the actin cytoskeleton, they 
do not directly interact with actin molecules.  Rather, Rho GTPases are signaling molecules that 
indirectly influence actin dynamics.
1.3 Rho GTPase Signaling Activity is Regulated by GAPs and GEFs
Rho GTPases can exist in an “on” (GTP-bound) state and an “off” (GDP-bound) state.  Therefore, 
these proteins are frequently referred to as molecular switches. When a Rho GTPase is in the “on” 
(GTP-bound) state, it can propagate a signal by interacting with downstream effector proteins.  These 
effector proteins can, in turn, activate other proteins, such as actin nucleators that promote the 
formation of new filaments (Fig. 1.6)10.
Figure 1.6:  Rho GTPases Can Exist in an “on” (GTP-bound) State and an “off” (GDP-
bound) State.  When a Rho GTPase is in the “on” (GTP-bound) state, it can propagate a signal by 
interacting with downstream effector proteins.  These effector proteins can, in turn, activate other 
proteins, such as actin nucleators that promote the formation of new filaments.  Conversion 
between the “on” and “off” states is regulated by GAP and GEF enzymes.  (This figure was taken 
from reference 10).
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As their name suggests, Rho GTPases are enzymes that can bind and hydrolyze GTP.  However, the 
intrinsic rates of hydrolysis for Rho GTPases are very slow.  Hydrolysis of GTP proceeds much faster 
in the presence of a GTPase Activating Protein (GAP).  A mechanism to explain how GAPs accelerate 
GTP hydrolysis has been proposed, based on crystallographic studies.  In each of these studies, a Rho 
GTPase / GAP complex was crystallized in the presence of GDP and an inorganic fluoride salt in order 
to trap the complex in a structure that mimics the transition state of the hydrolysis reaction (Fig. 
1.7A)11-13.  These structures suggest that a water molecule is positioned near the γ-phosphate of GTP in 
the transition state (Fig. 1.7B)11-13.   A new bond between this water molecule and the γ-phosphate 
appears to be forming as a P-O bond between the β- and γ-phosphate groups of GTP appears to be 
breaking (Fig. 1.7B)13.  Interactions between the carbonyl group on the catalytic Arg85 residue in the 
GAP (R85GAP, also referred to as the “arginine finger”) and the side chain of Gln63 (Q63) in RhoA (or 
Gln61 in Cdc42) help to orient the water molecule within the transition state (Fig. 1.7A)11-12.  These 
interactions stabilize the transition state and accelerate hydrolysis.
A
B
Figure 1.7:  GTPase Activating Proteins (GAPs) Stabilize the Transition State of the GTP 
Hydrolysis Reaction.  A RhoA / GAP complex was crystallized in the presence of GDP and an 
inorganic fluoride salt13.  Within this structure, the nucleotide, inorganic salt, and a water 
molecule are arranged in a pattern that corresponds to the transition state of the GTP hydrolysis 
reaction. (A) Cartoon showing specific interactions that were observed between amino acids in 
RhoA, the catalytic Arg85 (R85) amino acid in the GAP (R85GAP), and atoms in the GDP 
molecule, the inorganic salt, and the water molecule.  (B) Cartoon showing a proposed transition 
state of the GTP hydrolysis reaction that is based on the experimentally determined structural 
data depicted in (A).  (These figures were taken from reference 13).
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While GAPs promote the conversion of Rho GTPases from the active (GTP-bound) state to the inactive 
(GDP-bound) state, another group of enzymes, called Guanine nucleotide Exchange Factors (GEFs), 
promote the reverse process.  When a GEF binds to an inactive Rho GTPase, it causes conformational 
changes within the Rho GTPase that displace the bound GDP molecule and a Mg+2 cofactor (Fig. 1.8)14. 
In particular, a hydrophobic methyl group from Ala61 in RhoA displaces the Mg+2 cofactor, which 
lowers the affinity of RhoA for GDP15.  Furthermore, in the RhoA/GEF structure, a hydrogen bond 
between the Lys18 side chain in RhoA and GDP is lost, which further lowers the affinity of RhoA for 
GDP15.  Once the nucleotide is displaced, the Rho GTPase can bind to a new nucleotide.  Although it is 
possible that the Rho GTPase will bind to another GDP molecule, it is more probable that it will bind to 
a GTP molecule, since this form of the nucleotide is present at a higher concentration within the cell14.
A B
Figure 1.8:  GEFs Bind to Rho GTPases and Promote Dissociation of the Bound 
Nucleotide.  (A) This experimentally determined structure shows that RhoA can bind to GDP 
and a Mg+2 cofactor in the absence of a GEF.  (PDB code 1FTN16).  (B) When RhoA binds to 
Dbs, it undergoes conformational changes that displace both GDP and the Mg+2 cofactor 
(PDB code 1LB117).  In particular, a hydrophobic methyl group from Ala61 in RhoA 
displaces the Mg+2 cofactor, which lowers the affinity of RhoA for GDP15.  Furthermore, in 
this structure, a hydrogen bond between the Lys18 side chain in RhoA and GDP is lost, which 
further lowers the affinity of RhoA for GDP15.
It is important to note that, although the majority of the structural data for GEFs and GAPs have been 
acquired using soluble forms of these proteins, most of these enzymes have at least one domain that can 
interact with membranes18.  And, this interaction can play an important role in the activity of the 
enzyme.  For example, a Rac1-specific GAP called β2-chimaerin adopts a compact inactive 
conformation in the cytosol (Fig. 1.9A) and an elongated active structure when it is bound to acidic 
phospholipid membranes (Fig. 1.9B)19.  The C1 domain of β2-chimaerin binds to the lipid second 
messenger molecule diacylglycerol or to phorbol esters and plays an important role in translocating the 
GAP to membranes.
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Like β2-chimaerin, many GEFs and GAPs are capable of adopting an inactive autoinhibited 
conformation and most of these enzymes contain at least one domain that can interact with 
membranes18.  Therefore, it is possible that membrane binding may promote structural rearrangement 
of these enzymes in a manner similar to that observed with β2-chimaerin.  However, future studies are 
needed to determine whether this is the case.
A B
Figure 1.9: Membrane Binding Causes Conformational Changes in β2-Chimaerin.  (A) 
Structure of the inactive cytosolic conformation of β2-chimaerin determined by x-ray 
crystallography.  (B) Model of the active membrane-bound structure of β2-chimaerin.  In 
these figures, green represents hydrophobic residues, blue represents basic residues, red 
represents acidic residues, and white represents uncharged polar residues.  (These figures 
were taken from reference 19).
1.4 Prenylation Plays an Important Role in Rho GTPase Localization
Like most GEFs and GAPs, Rho GTPases can also interact with membranes.  In the latter case, this is 
due to a series of post-translational modifications that add a hydrophobic lipid tail to the C-termini of 
the proteins.
Most of the human Rho GTPases have a series of four amino acids known as a “CAAX” box at their C-
termini.  In this abbreviation, C represents a cysteine amino acid, A represents an aliphatic amino acid, 
and X represents the terminal amino acid.  The CAAX sequence of amino acids is recognized by 
specific enzymes within the cell (Fig. 1.10a)20-21.  First, the cysteine is prenylated by either a 
geranylgeranyltranserase (GGTase) or a farnesyltransferase (FTase) in the cytosol.  Although two of the 
~20 mammalian Rho GTPases are able to undergo either farnesylation or geranylgeranylation20,
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approximately half of the remaining members of this family of proteins appear to be exclusively 
farnesylated while the other half appear to be exclusively geranylgeranylated20.  The three most 
commonly studied Rho GTPases (Rac1, Cdc42, and RhoA) are geranylgeranylated20.  The prenylation 
of a Rho GTPase appears to play an important role in its localization and its signaling activities22-23.
Figure 1.10:  Prenylation Plays an Important Role in Rho GTPase Localization. (a) The 
CAAX sequence of amino acids is recognized by specific enzymes within the cell. First, the 
cysteine is prenylated.  Then, the Rho GTPase is localized to the endoplasmic reticulum 
(ER), where it is further modified by two more enzymes.  Ras-converting enzyme 1 (RCE1) 
removes the last 3 amino acids (-AAX) and isoprenylcysteine-O-carboxyl methyltransferase 
(ICMT) methylates the cysteine residue.  (b) The Rho GTPase can be extracted from the ER 
by a Rho Guanine nucleotide Dissociation Inhibitor (RhoGDI).  (c) In the absence of a  
RhoGDI, Rho GTPases can misfold and be targeted for degradation.  (d) The concentration 
of RhoGDI within the cell is finite.  Therefore, multiple Rho GTPases must compete with 
each other for the opportunity to bind to and be stabilized by a RhoGDI molecule. (e) Studies 
have shown that Rho GTPase mutants that are incapable of binding to RhoGDIs can still 
make their way to the plasma membrane.  These mutants may be transported to the plasma 
membrane by vesicles.  Similarly, vesicles may also be used to transport Rho GTPases away 
from the plasma membrane. (f) Conversion between the “on” and “off” states of the Rho 
GTPase is regulated by GAP and GEF enzymes. (g) Rho GTPases can be ubiquitinated by 
enzymes such as SMURF1 in order to target them for degradation.  (This figure was taken 
from reference 21).
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After a Rho GTPase is prenylated, it localizes to the endoplasmic reticulum (ER), where it is further 
modified by two additional enzymes.  Ras-converting enzyme 1 (RCE1) removes the last 3 amino acids 
(-AAX) and isoprenylcysteine-O-carboxyl methyltransferase (ICMT) methylates the cysteine residue.  
At this point, the Rho GTPase can be extracted from the ER by a Rho Guanine nucleotide Dissociation 
Inhibitor (RhoGDI) (Fig. 1.10b).  In fact, although the lipid tails of Rho GTPases can anchor them to 
membranes, the majority of Rho GTPases within a cell are bound to a RhoGDI in the cytosol21.
There are three mammalian isoforms of RhoGDI that are referred to as RhoGDI1, RhoGDI2, and 
RhoGDI3 (or RhoGDIα, RhoGDIβ, and RhoGDIγ).  However, only the RhoGDI1 isoform is 
ubiquitously expressed.  Furthermore, Rho GTPases have a higher binding affinity for the RhoGDI1 
isoform.  Therefore, most studies have focused on this isoform.
As its name suggests, RhoGDI1 prevents dissociation of the nucleotide from the Rho GTPase.  
Similarly, RhoGDI1 prevents nucleotide exchange (e.g., from GDP to GTP).  Moreover, RhoGDI1 
inhibits hydrolysis of GTP by the Rho GTPase both in the absence and in the presence of a GAP25.  
Therefore, when a  Rho GTPase is bound to RhoGDI1, it is effectively “locked” into one activity state.  
A helix-loop-helix motif referred to as the “regulatory arm” near the N-terminus of RhoGDI1 appears 
to be instrumental in inhibiting both nucleotide dissociation and GTP hydrolysis (Fig. 1.11).
Figure 1.11:  Structure of Cdc42 in Complex with RhoGDI1.  Cdc42 is colored in gold 
and RhoGDI1 is colored in blue.  A helix-loop-helix motif referred to as the “regulatory arm” 
near the N-terminus of RhoGDI1 appears to be instrumental in preventing nucleotide 
dissociation from Cdc42.  The geranylgeranyl tail of Cdc42 inserts into a gap between two 
antiparallel β-sheets at the C-terminus of RhoGDI1. (PDB code 1DOA24).
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When a Rho GTPase binds to RhoGDI1, its geranylgeranyl tail inserts into a gap between two 
antiparallel β-sheets at the C-terminus of RhoGDI1 (Fig. 1.11).  By shielding this hydrophobic tail from 
the aqueous environment of the cytosol, RhoGDI1 helps to prevent misfolding and degradation of the 
RhoGTPase (Fig. 1.10c).  However, the concentration of RhoGDI1 within the cell is finite.  Therefore, 
multiple Rho GTPases must compete with each other for the opportunity to bind to and be stabilized by 
a RhoGDI1 molecule (Fig. 1.10d).  This relatively recent finding suggests that overexpression of a Rho 
GTPase would disrupt this balance by introducing another pool of molecules that would compete with 
endogenous Rho GTPases for binding to RhoGDI1.
RhoGDI1 also helps to rapidly shuttle Rho GTPases between the cytosol and membranes (Fig. 1.10e).  
This shuttling provides an important mechanism to regulate Rho GTPase activity.  In particular, by 
sequestering Rho GTPases away from membranes, RhoGDI1 prevents Rho GTPases from engaging in 
signaling activities.  However, RhoGDI1 can also quickly release a Rho GTPase so that it can bind to a 
membrane, become activated by a GEF, and interact with downstream effectors (Fig. 1.10f).  The fast 
recycling of Rho GTPases between the cytosol and membranes may be regulated by kinases, that 
phosphorylate the Rho GTPase or RhoGDI1 and alter the binding affinity between these two 
molecules, and phosphatases that remove these phosphate groups21.
Although RhoGDI1 clearly plays an important role in shuttling Rho GTPases between the cytosol and 
membranes, the cell may employ other methods to shuttle Rho GTPases to membranes.  This would 
explain certain experimental results that showed that Rho GTPase mutants that are incapable of binding 
to RhoGDIs can still make their way to the plasma membrane.  These mutants may bind to vesicles and 
slowly be transported to the plasma membrane (Fig. 1.10e).  Similarly, vesicles can be used to transport 
Rho GTPases away from the plasma membrane.
1.5 Crosstalk Between Rho GTPases
Many studies have shown that one RhoGTPase can influence the behavior of other Rho GTPases.  This 
crosstalk can be the result of direct competition between the Rho GTPases for limited resources (e.g., 
RhoGDI1) or it can be indirect and involve activation or inactivation of an intermediate protein.
23
INTRODUCTION
                                                                                                                                                      
In general, Rho GTPases can influence each other at three different levels.  First, the activity of one 
Rho GTPase (R1) can influence the activity of another Rho GTPase (R2).  For example, when one Rho 
GTPase (R1) is activated, it could inactivate a GEF that is capable of activating a second Rho GTPase 
(R2) (Fig. 1.12a1).  Alternatively, R1 could activate a GAP that is capable of inactivating R2 (Fig 
1.12a2).  Second, R1 can directly influence the stability of R2 by displacing it from RhoGDI (Fig 
1.12a3).  Finally, R1 can interfere with the downstream signaling of R2 by inactivating a shared 
effector protein (Fig. 1.12a4) or a shared target protein (Fig. 1.12a5).  At each of these levels, the 
crosstalk may involve inhibition of R2 signaling by R1 (Fig. 1.12a).  Alternatively, activation of R1 
could also lead to enhancement of R2 signaling (Fig. 1.12b).
Figure 1.12:  Possible Modes of Crosstalk Between Two Rho GTPases (R1 and R2).  (A) 
Examples where activation of R1 leads to inhibition of R2 signaling.  (B) Examples where 
activation of R1 leads to enhancement of R2 signaling.  (These figures were taken from 
reference 26).
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Many studies have highlighted the roles of various GEFs, GAPs, and downstream effectors in 
regulating the crosstalk between Rac1 and RhoA (Fig. 1.13)26.  However, the extent to which each of 
these proteins regulates this crosstalk may vary, depending on the situation.  Furthermore, for each of 
these situations, the factors that determine which of these proteins are predominantly responsible for 
regulating this crosstalk remain poorly understood.
Figure 1.13:  Proposed Modes of Crosstalk Between Rac1 and RhoA.  (This figure was 
taken from reference 26).
Therefore, to directly measure the crosstalk between Rho GTPases, it would be best to develop a 
method to selectively perturb the activity of one Rho GTPase and to simultaneously measure how the 
activities of other Rho GTPases within the same cell respond to this perturbation (Fig. 1.14).  Ideally, 
these experiments would be repeated multiple times to account for cell-to-cell variability.
Figure 1.14:  Acute Perturbation and Activity Measurement of Rho GTPases in Living 
Cells.
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1.6 TIRF Microscopy
Although actin can be found throughout the cell, it is predominantly concentrated beneath the plasma 
membrane in a region known as the actin cortex (Fig. 1.4B).  Furthermore, regulation of actin dynamics 
by Rho GTPases often involves events that occur at or near the plasma membrane (Fig. 1.10).  
Therefore, experimental techniques that focus on this region of the cell can be used to study actin 
dynamics and its regulation by Rho GTPase signaling networks.  One such technique is that of Total 
Internal Reflection Fluorescence (TIRF) microscopy.
A B
C D
Figure 1.15:  Total Internal Reflection Fluorescence (TIRF) Microscopy.  (A) In 
epifluorescence microscopy, incident light excites fluorophores throughout a cell (green circles). 
(B) In TIRF microscopy, incident light is directed toward the interface formed by a glass cover 
slip and an aqueous sample such that the light undergoes total internal reflection (TIR)27,28.  This 
produces an evanescent field that penetrates into the aqueous sample.  However, the intensity of 
the evanescent field decreases exponentially with increasing distance from the glass/aqueous 
interface.  Therefore, the evanescent field can be used to selectively excite fluorophores in a cell 
that are close (50-300 nm) to the cover slip (green circles)27,28.  (C) A HeLa cell was fixed and 
the actin cytoskeleton of this cell was stained with a fluorescently labeled phalloidin.  This 
image was acquired using traditional epifluorescence microscopy.  (D) A TIRF image of the cell 
shown in (C).  (These figures were taken from references 27 and 28).
In TIRF microscopy, incident light is directed toward the interface formed by a glass cover slip and an 
aqueous sample such that the light undergoes total internal reflection (TIR) (Fig. 1.15B)27,28.  This 
produces an evanescent field that penetrates into the aqueous sample.  However, the intensity of the 
evanescent field decreases exponentially with increasing distance from the glass/aqueous interface.
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Therefore, the evanescent field can be used to selectively excite fluorophores in a cell that are close 
(50-300 nm) to the coverslip28.
TIRF microscopy can reveal details about the actin cytoskeleton that are obscured in traditional 
epifluorescence microscopy (Fig. 1.5C and Fig. 1.5D).
2. MATERIALS AND METHODS
2.1 Materials
2.1.1 Equipment and Consumables
Table 2.1: Equipment and Consumables Used for Mammalian Cell Culture
Description Catalogue Number / Model Company
Biosafety Cabinet NU-440-500E Nuaire
Cell Culture Vessels
100 mm Dish 353003 BD Falcon
4-well Lab-Tek™ I 155383 
Thermo Scientific 
Nunc4-well Lab-Tek™ II 155382 
8-well Lab-Tek™ I 155411
384-well Plate 781092 greiner bio-one
Centrifuge 5810 eppendorf
Centrifuge Rotor (swing-bucket) A-4-81 eppendorf
Cryo 1°C Freezing Container 5100-0001 Thermo Scientific
Cryogenic Tube 366656 Thermo Scientific Nunc
Freezer (-152ºC) MDF-1156 Sanyo
Hemacytometer Z359629 Sigma-Aldrich
Incubator HERAcell® 150 Thermo Scientific Heraeus
Microscope Eclipse TE200 Nikon
Lid (for 384-well Plates) 3099 Costar
Vacuum Filter (500 mL) 83.1823 Sarstedt
Water Bath 3047 Köttermann
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Table 2.2: Equipment and Consumables Used for Neurite Outgrowth Screens
Description Catalogue Number / Model Company
96-well Plate (sterile) 249946 Nalge Nunc
96-well Plate (sterile) 655 180 greiner bio-one
Disposable Reagent Reservoir, 
100 mL (sterile) HT71.1 Carl Roth GmbH & Co. KG
Microplate Sealing Film 60941-112 VWR
Multichannel Pipette, 850 μL Impact 2 Matrix
Multichannel Pipette, 125 μL Impact 2 Matrix
Pipette Tips, 1250 μL (sterile) 8042 Thermo Scientific Matrix
Pipette Tips, 1250 μL (non-sterile) 8046 Thermo Scientific Matrix
Pipette Tips, 125 μL (sterile) 7442 Thermo Scientific Matrix
Plate Reader infinite M1000 Tecan
Plate Washer ELx405 Select CW BioTek
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Table 2.3: Equipment and Consumables Used for Cloning
Description Catalogue Number / Model Company
Biological Shaker New Brunswick™ I26 eppendorf
Burner gasprofi 1 SCS micro WLD-TEC GmbH
Butane C206 super Campingaz
Butane Gas Regulator Typ 794 Cavagna Group
Camera (for gels) EX1 Samsung
Centrifuge
5417R eppendorf
5424 eppendorf
Centrifuge Rotor (fixed angle)
F-45-30-11 eppendorf
FA-45-24-11 eppendorf
Cuvette (disposable) 67.785 Sarstedt
Electrophoresis Chamber Mini-Plus-Unit HU10 biostep GmbH
Heating Block
DB-3D Techne
252-2 PMC
QBD4 Grant
Incubator 100-800 Memmert
PCR Thermocycler mastercycler ep 5341 eppendorf
UV lamp NU-6 KL Benda
UV Transilluminator (for gels) UST-20M-8E biostep GmbH
Table 2.4: Equipment and Consumables Used for Live and Fixed Cell Imaging
Description Catalogue Number / Model / Details Company
Immersion Oil Type-F IMMOIL-F30CC Olympus
Lens Cleaning Tissue 2105 841 Whatman
Microscope (widefield)
Olympus IX81,
Hamamatsu ORCA ER C4742-80-12AG Camera,
Objective = UPlans APO 10x NA,
Filters: BFP/GFP/RFP, Software: ScanˆR
Olympus
Microscope (widefield/TIRF)
Olympus IX81F-3,
Hamamatsu Image EM CCD-C9100-13 Camera,
Objective = PlanApo 60xOil TIRF (NA = 1.45), 
Lasers: 405 nm, 445 nm, 488 nm/514 nm, 561 nm,
Filters: BFP/GFP/RFP, YFP/CFP, TBFP/TGFP/TRFP,  
TBFP/TCFP/TYFP/TRFP, Software: CellˆR
Olympus
Microscope (confocol) LSM 510 MetaObjective = 40x water Zeiss
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Table 2.5: General Equipment and Consumables
Description Catalogue Number / Model Company
Aspiration Tool (for Vacuum Pump) VACUBOY Integra Biosciences
Balance PA114 Ohaus Corp.
Filter (for Vacuum Pump) 158015 Integra Biosciences
Freezer (-80ºC) New Brunswick™ U725-86 eppendorf
Gloves (Nitrile) 1280M Meditrade
Kimwipes 34155 Kimberly Clark
Parafilm® M H666.1 Carl Roth GmbH & Co. KG
pH Meter SevenEasy™ Mettler-Toledo GmbH
pH Sensor InLab® Expert Pro Mettler-Toledo GmbH
Pipette Controller accu-jet® pro Brand
Pipette (1 mL, 100 μL, 10 μL) Research eppendorf
Pipette Tips
1 mL 70.762 Sarstedt
200 μL 70.760.002 Sarstedt
20 μL 70.1114 Sarstedt
Serological Pipettes
25 mL 612-1245 VWR
10 mL 612-1248 VWR
5 mL 612-1270 VWR
Tubes
50 mL 62.547.254 Sarstedt
15 mL 62.554.502 Sarstedt
2 mL 72.695 Sarstedt
1.5 mL 72.704 Sarstedt
0.5 mL 72.706 Sarstedt
0.2 mL 72.737.002 Sarstedt
Vacuum Pump VACUSAFE comfort Integra Biosciences
Vortex Mixer G560E Scientific Industries
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2.1.2 Reagents
Table 2.6: Reagents Used for Mammalian Cell Culture
Description Catalogue Number Company
DMSO A994.1 Carl Roth GmbH & Co. KG
FBS 3302-P100309 PAN-Biotech GmbH
L-glutamine P04-80100 PAN-Biotech GmbH
MEM Eagle (for transfection) P04-00507 PAN-Biotech GmbH
MEM Eagle (for N2a cells) P04-08050 PAN-Biotech GmbH
Penicillin/Streptomycin P06-07100 PAN-Biotech GmbH
Sodium Pyruvate P04-43100 PAN-Biotech GmbH
Trypsin-EDTA P10-023100SP PAN-Biotech GmbH
X-tremeGENE 9 06 365 787 001 Roche Diagnostics GmbH
Table 2.7: Reagents Used for Neurite Outgrowth Screens
Description Catalogue Number Company
Chondramide C -
Max Planck Institute of 
Molecular Physiology – 
Dortmund
DMSO A994.1 Carl Roth GmbH & Co. KG
Jasplakinolide sc-202191A Santa Cruz Biotechnology
Taxol T7402 Sigma-Aldrich
WST-1 Cell Proliferation Reagent 11 644 807 001 or 05 015 944 001 Roche Diagnostics GmbH
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Table 2.8: Reagents and Kits Used for Cloning
Description Catalogue Number Company
Acetic Acid 45726 Sigma-Aldrich
Agarose T846.2 or T846.3 Carl Roth GmbH & Co. KG
Antibiotics
Ampicillin K029.1 Carl Roth GmbH & Co. KG
Kanamycin T832.1 Carl Roth GmbH & Co. KG
Big Dye Terminator Mix 06112-1
Max Planck Institute of 
Molecular Physiology – 
Dortmund
Buffers
NEBuffer 1 B7001S New England Biolabs
NEBuffer 2 B7002S New England Biolabs
NEBuffer 3.1 B7203S New England Biolabs
NEBuffer 4 B7004S New England Biolabs
NEBuffer EcoRI B0101S New England Biolabs
Phusion® HF Reaction 
Buffer (5x) B0519S Ambion
T4 DNA Ligase Buffer 
(10x) with 10 mM ATP B0202S New England Biolabs
TAE Buffer (1x) 40 mM Tris-acetate (pH 8.0),1 mM EDTA -
Culture Tubes (sterile) T406-2A Simport
dNTP Mix (10 mM each) -
Max Planck Institute of 
Molecular Physiology – 
Dortmund
Na2EDTA • 2H2O E5134 Sigma-Aldrich
Enzymes
AgeI R0552S New England Biolabs
Antarctic Phosphatase M0289L or M0289S New England Biolabs
AseI R0526S New England Biolabs
BamHI R0136S New England Biolabs
BsrGI R0575S New England Biolabs
EcoRI R0101L New England Biolabs
MfeI R0589S New England Biolabs
MluI R0198S New England Biolabs
NgoMIV R0564S New England Biolabs
NheI-HF R3131S New England Biolabs
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Table 2.8: Reagents and Kits Used for Cloning (continued)
Description Catalogue Number Company
Enzymes
Phusion® DNA Polymerase F530S or F530L Finnzymes
T4 DNA Ligase M0202S New England Biolabs
XbaI R0145L New England Biolabs
XhoI R0146S New England Biolabs
Ethidium Bromide (0.025%) HP47.1 Carl Roth GmbH & Co.KG
Gene Ruler™ 1kb DNA Ladder SM0311 or SM0314 Fermentas
Glycerol G2025 Sigma-Aldrich
Isopropanol 6752.1 Carl Roth GmbH & Co.KG
Kits
Plasmid Purification Kit 27106 Qiagen
Gel Extraction Kit 28706 Qiagen
PCR Purification Kit 28106 Qiagen
Loading Dye (5x, Gel Pilot) 239901 Qiagen
LB (Luria-Bertani) medium -
Max Planck Institute of 
Molecular Physiology – 
Dortmund
LB agar plates -
Max Planck Institute of 
Molecular Physiology – 
Dortmund
Scalpel 5518091 B. Braun
Sodium Acetate 0258 J.T. Baker
Sodium Chloride (NaCl) 71376 Sigma-Aldrich
Sodium Hydroxide 71689 Sigma-Aldrich
Trizma Base T6066 Sigma-Aldrich
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Table 2.9: Reagents Used for Live and Fixed Cell Imaging
Description Catalogue Number Company
Alexa Fluor® 488 Phalloidin A12379 Invitrogen
Antibodies
Anti-α-Tubulin Antibody 
Produced in Mouse T5168 Sigma-Aldrich
Alexa Fluor® 568 Goat 
Anti-Mouse IgG (H+L) 
Antibody
A-11004 Invitrogen
BSA 11930.03 SERVA Electrophoresis GmbH
DMEM (for imaging media) P04-01163 PAN-Biotech GmbH
FBS 3302-P100309 PAN-Biotech GmbH
Formaldehyde Solution 
(37 wt. % in H2O)
533998 Sigma-Aldrich
Hoechst 33342 B2261 Sigma-Aldrich
Potassium Phosphate Monobasic P9791 Sigma-Aldrich
Potassium Choride P9541 Sigma-Aldrich
Sodium Chloride 71376 Sigma-Aldrich
Sodium Phosphate Dibasic Heptahydrate X987.1 Carl Roth GmbH & Co.KG
Triton® X-100 37240 SERVA Electrophoresis GmbH
Table 2.10: General Reagents
Description Catalogue Number Company
Absolute Ethanol 20821.265 AnalaR Normapur
Buffer Solution
pH = 4.01 340-1000040240 Mercateo
pH = 7.00 340-1000072640 Mercateo
pH = 10.00 340-1000103840 Mercateo
Hydrochloric acid (HCl) H1758 Sigma-Aldrich
Nuclease-free Water AM9932 New England Biolabs
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2.1.3 Cell Lines
Table 2.11: Cell Lines Used for Mammalian Cell Culture
Cell Line Species Cell Type Morphology DSMZ Nr.
Neuro-2a Mouse Embryo Neuroblast ACC 148
Table 2.12: Cell Lines Used for Cloning
Cell Line Genotype Company
Top 10 F
– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔ M15 Δ lacX74 recA1 araD139 
Δ(ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG Λ- Invitrogen
XL10Gold TetR Δ(mcrA)183 Δ(mcrCB-hsdSMR mrr) 173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F' proAB lacIqZ Δ M15 Tn10(TetR) Amy CamR] Stratagene
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2.1.4 Primers and Plasmids
Table 2.13: Primers Used for Cloning (ordered from Sigma-Aldrich)
Name Typea Sequenceb
PAK1_forward For 5'-TAGGCTGGGAATTCCAAGAAAGAGAAAGAGCGGCC-3'
PAK1_reverse Rev 5'-TCGGCGCGGGATCCCTATGACTTATCTGTAAAGC3'
RBD_forward For 5'-CTCAGATCGAATTCCCTGGAGGACCTCAATATGC-3'
RBD_reverse Rev 5'-CCCGCGGTGGATCCCTAGCCTGTCTTCTCCAGC -3'
rGBD_forward For 5'-CTCAGATCGAATTCCATCCTGGAGGACCTC-3'
rGBD_reverse Rev 5'-CTCACTATGGATCCCTAGCCTGTCTTCTCCAGC-3'
p67phox aa1-203 forward For 5'-CAAGCTTCGAATTCCATGTCCCTGGTGGAGGCC-3'
p67phox aa1-203 reverse Rev 5'-GATCCGGTGGATCCCTACGTCGCCTTGCCTAGG-3'
WASP-GBD_forward For 5'-GCCCCCTTGAATTCCGACATCCAGAACCCTGAC-3'
WASP-GBD_reverse Rev 5'-GATGCATGGGATCCCTATCGAGATGGCGGTGG-3'
BsrGI-Start-Rac For 5'-GGAGGTGTACAAGTCCATGCAGGCCATCAAGTGTG-3'
Rac-XhoI Rev 5'-AATTCTACTCGAGGCAGGGATTTTCTCTTCCTCTTC-3'
XbaI-Start-Rac For 5'-GGAGGAGTCTAGATCCATGCAGGCCATCAAGTGTG-3'
Rac-Stop-MfeI Rev 5'-AATTCTCAATTGAGTTAGGATTTTCTCTTCCTCTTC-3'
NheI-Start-Rac For 5'-GGAGGAGCTAGCATCCATGCAGGCCATCAAGTGTG-3'
Rac-NgoMIV Rev 5'-AATTCTGCCGGCAGCAGGGATTTTCTCTTCCTCTTC-3'
NheI-linker For 5'-TCAGTTGCTAGCCTCAAGCTTCGAATTCTG-3'
NES-BsrGIc Rev 5'-AGAGTCAGCTCGAGATATCTTGTACGAGTCCAG-3'
XbaI-Cdc42 For 5'-CTGTACTCTAGATCCATGCAGACAATTAAGTG-3'
Cdc42-S-Stop Rev 5'-TCGAGTCAATTGAGTTAGGACCTGCGGCTCTTC-3'
FW-XbaI-RhoA-Q63L For 5'-GGAATTCTAGATCCATGGCTGCCATCCGGAAG-3'
RhoA-S-Stop2 Rev 5’-CGAGTCAATTGAGTTAGGAACCAGATTTTTTC-3'
Xho-linker For 5'-AGCTGTCTCGAGGTTCTGGAAGTGGATCC-3'
MfeI-linker Rev 5'-GTGGTGCAATTGATCCTCGGGGTCTTC-3'
a) For = forward, Rev = reverse
b) Restriction sites are highlighted in brown; extra bases added to ensure insertion into the proper reading 
frame are highlighted in yellow; start and stop codons are shown in bold
c) Although the name of this primer implies that it has a BsrGI restriction site, it actually has a XhoI 
restriction site.
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Table 2.14: Primers Used for Sequencing (ordered from Sigma-Aldrich)
Name Type Sequence
Seqmyctag Forward 5'-GAACAAAAACTCATCTCAGAAGAGGATCTG-3'
T7forward Forward 5'-TAATACGACTCACTATAGGG-3'
mCherryC Forward 5'-GCCCGGCGCCTACAACGTC-3'
N1-delCMV Forward 5'-TCCGCGTTACATAACTTACGG-3'
SeqUb_833_s Forward 5'-CACATGAAGCAGCACGACTT-3'
pEGFP-C11266s Forward 5'-CATGGTCCTGCTGGAGTTCGTG-3'
pEGFP-N1500F Forward 5'-TAACAACTCCGCCCCATTGAC-3'
delCMVseq Forward 5'-ATATATGGAGTTCCGCGTTA-3'
pEGFP-C11266F Forward 5'-CATGGTCCTGCTGGAGTTCGTG-3'
LOV-F Forward 5'-AGAGAGAGGGAGTCATGCTGAT-3'
hRac1-F Forward 5'-AACCAATGCATTTCCTGGAG-3'
pBABE_3_rev Reverse 5'-ACCCTAACTGACACACATTCC-3'
Terminator reverse Reverse 5'-AGTGGCACCTTCCAGGGTCAA-3'
NotI-EGFP-concat Reverse 5'-CTAGAGTCGCGGCCGCTTTACTTG-3'
mCherryN Reverse 5'-GCCCTCGCCCTCGATCTCG-3'
pEGFP-N1771R Reverse 5'-GACACGCTGAACTTGTGGC-3'
pEGFP-N11548R Reverse 5'-GTAACCATTATAAGCTGCAATAAAC-3'
GFPseq_141as Reverse 5'-GAACTTCAGGGTCAGCTTGCCGT-3'
hRac1-R Reverse 5'-GATACCACTTTGCACGGACA-3'
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Table 2.15: Mammalian Expression Plasmids
Name Description of the Expressed Protein SourceReference
pmCherry-N1 mCherry Max Planck Institute of Molecular Physiology (Dortmund)
delCMV-mCherry mCherry This thesis
pmCitrine-N1 mCitrine Max Planck Institute of Molecular Physiology (Dortmund)
delCMV-mCitrine mCitrine This thesis
pmCherry-actin-UB mCherry labeled actin
Melanie Gräßl/Verena Hannak 
(Technical University of 
Dortmund)
pmCherry-actin-delCMV mCherry labeled actin Verena Hannak (Technical University of Dortmund)
pΔSV40-PAK-GBD-mCherry
(pAL197)
The GTPase binding domain (GBD) of 
PAK1 linked to mCherry
Christopher A. Voigt (University 
of California, San Fransicso)29
pΔSV40-mCherry-WASP-
GBD (pAL198)
mCherry linked to the GTPase binding 
domain (GBD) of WASP
Christopher A. Voigt (University 
of California, San Fransicso)29
mCherry-Rhotekin(8-89)-
mCherry-C1
The GTPase binding domain (GBD) of 
Rhotekin flanked by mCherry tags at 
the N-terminus and the C-terminus
Ryohei Yasuda (Duke University 
Medical Center, Durham, North 
Carolina)30
GFP-rGBD GFP linked to the GTPase binding domain (GBD) of Rhotekin
William M. Bement (University 
of Wisconsin-Madison)31
pGEX-4T-I-p67phox-aa1-203 The Rac1 GTPase binding domain (GBD) of p67phox
Mohammad Reza Ahmadian 
(Heinrich–Heine-University, 
Düsseldorf)
delCMV-mCherry-p67phox (aa1-
203)
mCherry linked to the Rac1 GTPase 
binding domain (GBD) of p67phox
Djamschid Solouk (Ruhr 
University, Bochum)32
delCMV-mCherry-PAK-GBD
mCherry linked to the Rac1/Cdc42 
GTPase binding domain (GBD) of 
PAK1
This thesis
delCMV-mCherry-RBD mCherry linked to the GTPase binding domain (GBD) of Rhotekin This thesis
delCMV-mCherry-rGBD mCherry linked to the GTPase binding domain (GBD) of Rhotekin This thesis
delCMV-mCherry-WASP-
GBD
mCherry linked to the Cdc42 GTPase 
binding domain (GBD) of WASP This thesis
C1-EGFP-DNIC2-delCMV EGFP linked to dynein intermediate chain 2 (DNIC2)
Anja Biesemann (Ruhr 
University, Bochum)33
delCMV-EGFP-tubulin EGFP linked to tubulin Julia Arens (TechnicalUniversity of Dortmund)34
delCMV-EGFP-p67phox (aa1-
203)
EGFP linked to the Rac1 GTPase 
binding domain (GBD) of p67phox This thesis
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Table 2.15: Mammalian Expression Plasmids (continued)
Name Description of the Expressed Protein SourceReference
PA-Cdc42Q61L-Venus A Venus labeled photoactivatable (PA) Cdc42
Klaus Hahn (University of North 
Carolina, Chapel Hill)35
PA-Cdc42Q61L-mCherry An mCherry labeled photoactivatable (PA) Cdc42
Klaus Hahn (University of North 
Carolina, Chapel Hill)35
mCerulean-PA-Cdc42Q61L An mCerulean labeled photoactivatable (PA) Cdc42
Johannes Koch (University of 
Duisburg-Essen)
PA-Rac1Q61L-Venus A Venus labeled photoactivatable (PA) Rac1
Klaus Hahn (University of North 
Carolina, Chapel Hill)35
PA-Rac1Q61L-mCherry An mCherry labeled photoactivatable (PA) Rac1
Klaus Hahn (University of North 
Carolina, Chapel Hill)35
mCerulean-PA-Rac1Q61L An mCerulean labeled photoactivatable (PA) Rac1
Klaus Hahn (University of North 
Carolina, Chapel Hill)35
delCMV-mTurquoise2-NES-
PA-Rac1Q61L
mTurquoise2 linked to a nuclear export 
sequence (NES) and a photoactivatable 
(PA) Rac1
This thesis
TagBFP-2×eDHFR-CAAX
TagBFP linked to 2 copies of E. coli 
dihydrofolate reductase (eDHFR) and 
the C-terminus of Kras (KRC)
Yao-Wen Wu (Chemical 
Genomics Centre of the Max 
Planck Society, Dortmund/Max-
Planck-Institute of Molecular 
Physiology, Dortmund)
pEGFP-2×FKBP'
EGFP linked to 2 copies of the F36V 
mutant of FK506-binding protein 
(FKBP)
Yao-Wen Wu (Chemical 
Genomics Centre of the Max 
Planck Society, Dortmund/Max-
Planck-Institute of Molecular 
Physiology, Dortmund)
Rac1Q61L A constitutively active mutant of Rac1 Gary Bokoch (The Scripps Research Institute, CA)
pcDNA3-EGFP-Cdc42Q61L An EGFP labeled constitutively active mutant of Cdc42
Gary Bokoch (The Scripps 
Research Institute, CA)
pcDNA3-EGFP-RhoA-Q63L An EGFP labeled constitutively active mutant of RhoA
Gary Bokoch (The Scripps 
Research Institute, CA)
Rac1Q61LΔCAAX-EGFP-
2×FKBP'
A constitutively active mutant of Rac1 
linked to EGFP and 2 copies of the 
F36V mutant of FK506-binding protein 
(FKBP)
This thesis
EGFP-Rac1Q61LΔCAAX-
2×FKBP'
EGFP linked to a constitutively active 
mutant of Rac1 and 2 copies of the 
F36V mutant of FK506-binding protein 
(FKBP)
This thesis
EGFP-2×FKBP'- 
Rac1Q61LΔCAAX
EGFP linked to 2 copies of the F36V 
mutant of FK506-binding protein 
(FKBP) and a constitutively active 
mutant of Rac1
This thesis
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Table 2.15: Mammalian Expression Plasmids (continued)
Name Description of the Expressed Protein SourceReference
delCMV-EGFP-2×FKBP'- 
Rac1Q61LΔCAAX
EGFP linked to 2 copies of the F36V 
mutant of FK506-binding protein 
(FKBP) and a constitutively active 
mutant of Rac1
This thesis
pmTurquoise2-C1 mTurquoise2 Max Planck Institute of Molecular Physiology (Dortmund)
pmTurquoise2-NES An mTurquoise2 labeled nuclear export sequence (NES)
Theodorus W.J. Gadella Jr 
(University of Amsterdam) and 
Antoine Royant (Institute of 
Structural Biology, Grenoble)36
mTurquoise2-NES-2×FKBP'
mTurquoise2 linked to a nuclear export 
sequence (NES) and 2 copies of the 
F36V mutant of FK506-binding protein 
(FKBP)
This thesis
delCMV-mTurquoise2-NES-
2×FKBP'
mTurquoise2 linked to a nuclear export 
sequence (NES) and 2 copies of the 
F36V mutant of FK506-binding protein 
(FKBP)
This thesis
mTurquoise2-2×FKBP'-
Rac1Q61LΔCAAX
mTurquoise2 linked to 2 copies of the 
F36V mutant of FK506-binding protein 
(FKBP) and a constitutively active 
mutant of Rac1
This thesis
delCMV-mTurquoise2-
2×FKBP'-Rac1Q61LΔCAAX
mTurquoise2 linked to 2 copies of the 
F36V mutant of FK506-binding protein 
(FKBP) and a constitutively active 
mutant of Rac1
This thesis
mTurquoise2-NES-2×FKBP'-
Rac1Q61LΔCAAX
mTurquoise2 linked to a nuclear export 
sequence (NES), 2 copies of the F36V 
mutant of FK506-binding protein 
(FKBP), and a constitutively active 
mutant of Rac1
This thesis
delCMV-mTurquoise2-NES-
2×FKBP'-Rac1Q61LΔCAAX
mTurquoise2 linked to a nuclear export 
sequence (NES), 2 copies of the F36V 
mutant of FK506-binding protein 
(FKBP), and a constitutively active 
mutant of Rac1
This thesis
mTurquoise2-NES-2×FKBP'-
Cdc42Q61LΔCAAX
mTurquoise2 linked to a nuclear export 
sequence (NES), 2 copies of the F36V 
mutant of FK506-binding protein 
(FKBP), and a constitutively active 
mutant of Cdc42
This thesis
delCMV-mTurquoise2-NES-
2×FKBP'-Cdc42Q61LΔCAAX
mTurquoise2 linked to a nuclear export 
sequence (NES), 2 copies of the F36V 
mutant of FK506-binding protein 
(FKBP), and a constitutively active 
mutant of Cdc42
This thesis
40
MATERIALS AND METHODS
                                                                                                                                                      
Table 2.15: Mammalian Expression Plasmids (continued)
Name Description of the Expressed Protein SourceReference
mTurquoise2-NES-2×FKBP'-
RhoAQ63LΔCAAX
mTurquoise2 linked to a nuclear export 
sequence (NES), 2 copies of the F36V 
mutant of FK506-binding protein 
(FKBP), and a constitutively active 
mutant of RhoA
This thesis
delCMV-mTurquoise2-NES-
2×FKBP'-RhoAQ63LΔCAAX
mTurquoise2 linked to a nuclear export 
sequence (NES), 2 copies of the F36V 
mutant of FK506-binding protein 
(FKBP), and a constitutively active 
mutant of RhoA
This thesis
2.2 Methods
2.2.1 Mammalian Cell Culture and Transfection
All procedures involving direct handling of Neuro-2a (N2a) cells were performed in a biosafety cabinet 
(Nuaire). Some reagents (e.g., N2a medium, Trypsin-EDTA, etc.) were pre-warmed in a 37°C water 
bath (Köttermann). Other reagents (e.g., X-tremeGENE 9 transfection reagent) were used at room 
temperature (RT).
N2a cells were seeded onto a 100 mm culture dish (BD Falcon) containing 10 mL of warm N2a 
medium (Table 2.16). Then, the cells were incubated at 5% CO2 and 37°C.
Table 2.16: Preparation of 500 mL of N2a Mediuma
Component Company Volume (mL)
FBS PAN-Biotech GmbH 50
Penicillin/Streptomycin PAN-Biotech GmbH 5
L-glutamine PAN-Biotech GmbH 5
Sodium Pyruvate PAN-Biotech GmbH 5
MEM Eagle PAN-Biotech GmbH 435
a) After the medium was prepared, it was passed through a sterile vacuum filter (Sarstedt)
41
MATERIALS AND METHODS
                                                                                                                                                      
Whenever the cells were deemed to be ~70-80% confluent (typically every 2-3 days), the cells were 
detached from the culture dish and ~400 – 600 μL of the re-suspended cells was seeded onto a new 100 
mm culture dish (BD Falcon) containing 10 mL of warm N2a medium. Detachment was performed in 
three steps.  In the first step, the cells were washed with 1 mL of warm Trypsin-EDTA (PAN-Biotech 
GmbH).  In the second step, the cells were incubated with 2 mL of warm Trypsin-EDTA (PAN-Biotech 
GmbH) at 5% CO2 and 37°C for ~6 minutes.  Finally, 5 mL of warm N2a medium was added to the 
dish and the cells were re-suspended using a 10 mL serological pipette.
For long-term storage, re-suspended N2a cells from 5-10 dishes were combined and centrifuged at 
1000 rpm and 4°C for 5 minutes. Then, the supernatant was discarded and the pellet was re-suspended 
in 5-10 mL of cold N2a medium containing 10% DMSO.  The re-suspended cells were aliquoted into 1 
mL cryotubes (Thermo Scientific Nunc) and transferred to a Cryo 1°C Freezing Container (Thermo 
Scientific).  The Container was stored overnight at -80°C.  Then, the cryotubes were transferred to a 
-152°C freezer (Sanyo).
For microscopy experiments, re-suspended N2a cells were seeded onto an appropriate cell culture 
vessel (e.g., a 4-well Lab-Tek™ I, a 4-well Lab-Tek™ II, an 8-well Lab-Tek™ I, or a 384-well Plate).
For certain microscopy experiments, N2a cells were transfected with one or more mammalian 
expression plasmids (Table 2.15). Transfection of N2a cells was performed with the X-tremeGENE 9 
transfection reagent (Roche).  First, 3 μL of transfection reagent was diluted with 100 μL of MEM 
Eagle (PAN-Biotech).  Then, the diluted transfection reagent was added to the plasmid DNA to a final 
ratio of 1 μg of DNA/3 μL of transfection reagent.  While the DNA/transfection reagent solution 
incubated at RT for ~30 minutes, fresh, warm N2a medium was added to the cells.  Then, the 
DNA/transfection reagent solution was added to the cells.
2.2.2 Neurite Outgrowth Screens and Proliferation Assays
For neurite outgrowth screens, 5 μL of warm N2a medium was added to each well of a 384-well plate 
(greiner bio-one).  Then, the plate was centrifuged at 1000 rpm for 1 minute.  Re-suspended N2a cells 
were diluted with warm N2a medium to a final density of 37,500 cells/mL.  And, 80 μL of the diluted 
cells was added to each well of the 384-well plate (~3000 cells/well).  The cells were incubated 
overnight at 5% CO2 and 37°C.
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DMSO solutions of synthetic analogues and reference compounds were supplied by chemists at the 
Max Planck Institute of Molecular Physiology.  These solutions were serially diluted with warm N2a 
medium containing taxol (Sigma-Aldrich) and the diluted solutions were added to the cells. Serially 
diluted DMSO solutions were used as controls. For each well containing a compound or DMSO, the 
final concentration of taxol was 1 μM.  The compounds were initially tested at the following 
concentrations:  15.00 μM, 5.00 μM, 1.67 μM, 555.56 nM, 185.19 nM, 61.73 nM, 20.58 nM, 6.86 nM, 
2.29 nM, 762.08 pM, 254.03 pM, and 84.68 pM.  However, selected experiments were also performed 
at the following concentrations: 28.23 pM, 9.41 pM, 3.14 pM, 1.05 pM, 348.46 fM, 116.15 fM, 38.72 
fM, 12.91 fM, 4.30 fM, 1.43 fM, 0.48 fM, and 0.16 fM.  The cells were incubated in the presence of the 
compounds or DMSO for 2 hours at 5% CO2 and 37°C.  Each experiment was performed in triplicate.  
For reference, some wells contained cells without any compound or DMSO.
Then, the cells were fixed by replacing the N2a medium in each well of the plate with warm 4 % 
formaldehyde in 1x PBS (Table 2.17) and incubating the cells at 37°C for 20 minutes.
Table 2.17: Preparation of 1 L of 1x PBS
Component Company Quantity
Sodium Chloride (NaCl) Sigma-Aldrich 8.00 g
Potassium Chloride (KCl) Sigma-Aldrich 0.20 g
Potassium Phosphate Monobasic (KH2PO4) Sigma-Aldrich 2.68 g
Sodium Phosphate Dibasic Heptahydrate (Na2HPO4  • 7H2O) Sigma-Aldrich 0.24 g
Hydrochloric Acid (HCl) Sigma-Aldrich enough to adjust the pH to 7.4
ddH2O Milipore
enough to adjust 
the volume to 1L
The procedure described in Table 2.18 was used to stain the actin filaments, microtubules, and nuclei of 
the cells.
For the proliferation assays,  re-suspended N2a cells were diluted with warm N2a medium to a final 
density of 10,000 cells/mL.  And, 200 μL of the diluted cells was added to each well of a 96-well plate 
(Nalge Nunc).  The cells were incubated overnight at 5% CO2 and 37°C.
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Table 2.18: Procedure Used to Stain the Fixed N2a cells
Step Description Solution Temperature (°C)a Duration
1. Wash the cells 5 times 1x PBS containing 0.01% Triton® X-100 RT -
2. Permeabilization 1x PBS containing 0.25% Triton® X-100 RT 15 min.
3. Wash the cells 5 times 1x PBS containing 0.001% Triton® X-100 RT -
4. Blocking 10% BSA in 1x PBS 37 30 min.
5. Primary staining of microtubules
1:5000 dilution of anti-α-tubulin antibody 
(mouse) in 1% BSA/PBS 37 1 hour
6. Wash the cells 5 times 1x PBS containing 0.001% Triton® X-100 RT -
7.
Secondary staining of 
microtubules, staining of 
the nuclei, staining of 
actin
1:1000 dilution of Alexa-568 anti-mouse 
antibody, 1:1000 dilution of Hoechst stock 
solution, 1:1000 dilution of Alexa-488-
phalloidin in 1% BSA/PBS to the rinsed 
media reservoir.
37 1 hour
8. Wash the cells 5 times 1x PBS containing 0.001% Triton® X-100 RT -
a) RT = room temperature
DMSO solutions of synthetic analogues were supplied by chemists at the Max Planck Institute of 
Molecular Physiology.  Each of these solutions was serially diluted with DMSO to prepare a series of 
ten 100x stock solutions.  Then, each of the 100x stock solutions was diluted to 1x with warm N2a 
medium and the diluted solutions were added to the cells.  For each well containing a compound, the 
final concentration of DMSO was 1% (v/v).  The compounds were tested at the following 
concentrations: 60.00 μM, 20.00 μM, 6.67 μM, 2.22 μM, 740.74 nM, 246.91 nM, 82.30 nM, 27.43 nM
9.14 nM, 3.05 nM . Each experiment was performed in quadruplicate.
The cells were incubated in the presence of the compounds for 3 days at 5% CO2 and 37°C.  Then, 10 
μL of WST-1 Cell Proliferation Reagent (Roche) was added to each of the wells.  And, the cells were 
incubated for 1.5-2 hours at 5% CO2 and 37°C.  Finally, for each well, the absorbance at 450 nm (A450) 
and the absorbance at 650 nm (A650) was measured using a plate reader (Tecan).
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2.2.3 Cloning
In general, a new plasmid was constructed by combining two DNA fragments together (Fig. 2.1).
A
B
C
Figure 2.1: Isolation of DNA Fragments Used for Cloning.  (A) Isolation of 
the “backbone” fragment.  (B) Isolation of the “insert” fragment by PCR 
amplification.  (C) Isolation of the “insert” fragment by digestion of an 
existing plasmid.  (These figures were taken from the New England Biolabs 
website, https://www.neb.com).
One of the fragments, hereafter referred to as the “backbone” fragment, was generated by digesting an 
existing mammalian expression plasmid with two unique restriction enzymes (Fig. 2.1A). For each μg 
of plasmid, 5 U of each enzyme was used (Table 2.19). And, the digestions were incubated for 2 hours 
at 37°C. Whenever possible, the restriction enzymes were heat inactivated according the the 
manufacturer's instructions. Then, the 5' phosphates of the DNA were removed by addition of 1 μL of 
Antarctic Phosphatase (New England Biolabs) followed by 1 hour of incubation at 37°C. The  Antarctic 
Phosphatase was also heat inactivated according the the manufacturer's instructions. Then, the DNA 
was purified by electrophoresis using a 1% agarose gel (Table 2.20) and the fragment of interest was 
isolated using a QIAquick Gel Extraction Kit (Qiagen).
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Table 2.19: Example of Double Digestion Conditions
Component Volume Initial Concentration Final Concentration
Nuclease-free Water 2.5 μL - -
Buffer = NEBuffer EcoRI 1.5 μL 10x 1x
DNA= delCMV-mCherry-actin 9.0 μL 0.442 μg/μL 0.265 μg/μL
BamHI 1.0 μL 20,000 U/mL 1333 U/mL
EcoRI 1.0 μL 20,000 U/mL 1333 U/mL
The second fragment, hereafter referred to as the “insert” fragment, was frequently prepared using 
polymerase chain reaction (PCR) amplification (Fig. 2.1B, Table 2.21, Table 2.22).  A plasmid 
containing the sequence of interest was used as the template DNA.  And, forward and reverse primers 
(Table 2.13) were designed so that the amplified DNA would contain the sequence of interest, flanked 
by restriction sites that matched those used to prepare the backbone fragment.
Table 2.20: Example of Gel Electrophoresis Conditions
Gel Volume Gel Composition Running Buffer Loading Dye Voltage Duration
100 mL 1% agarose in 1x TAE with 4 drops of ethidium bromide 1x TAE
GelPilot 
(Qiagen) ~85V 1 hour
Table 2.21: Example of Polymerase Chain Reaction (PCR) Amplification Conditions
Component Volume Initial Concentration Final Concentration
Nuclease-free Water 32.5 μL - -
Phusion® HF Reaction Buffer 10.0 μL 5x 1x
dNTPs 1.0 μL 10 mM each 200 μM each
Forward Primer 2.5 μL 10 μM 0.5 μM
Reverse Primer 2.5 μL 10 μM 0.5 μM
Template DNA 1.0 μL 10 ng/μL 200 pg/μL
Phusion® DNA Polymerase 0.5 μL 2 U/μL 0.02 U/μL
The following PCR program was used:
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Table 2.22:  PCR Program Used for Amplification
Repetitions T (°C) Time
1 98 3 min.
20
98 10 sec.
68 30 sec.
72 15 sec.a
1 72 8 min.
1 8 ∞
a) For amplification of mTurquoise2-NES 
and PA-Rac1, 1 minute was used.
The amplified insert DNA was purified using a QIAquick PCR Purification Kit (Qiagen).  Then, the 
insert DNA was digested with appropriate restriction enzymes (Table 2.19).  The digested insert 
fragment was purified by electrophoresis using a 1% agarose gel (Table 2.20) and the fragment of 
interest was isolated using a QIAquick Gel Extraction Kit (Qiagen).
On rare occasions, it was not necessary to use PCR to isolate the insert fragment.  In these instances, it 
was possible to directly digest an existing plasmid to produce an insert fragment that could be ligated 
with the backbone fragment (Fig. 2C).
Once the backbone and insert fragments were prepared and purified, they were ligated together.  For 
each ligation, the backbone fragment and the insert fragment were combined in a roughly 1:1 molar 
ratio and 500 U of T4 DNA Ligase (New England Biolabs) was used (Table 2.23).  Ligations were 
typically incubated overnight at 16°C.
Table 2.23:  Example of Conditions Used for a Ligation
Component Volume (μL) Initial Concentration Final Concentration
PCR Product (~619 bp) 14.6 32 ng/μL 11.68 ng/μL
Backbone Fragment (~4247 bp) 20.2 162 ng/μL 81.81 ng/μL
T4 Ligase Buffer (with ATP) 4.00 10x 1x
T4 Ligase 1.25 400,000 U/mL 12,500 U/mL
The following table summarizes the fragments that were ligated together to produce new mammalian 
expression plasmids:
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Table 2.24:  Summary of New Mammalian Expression Plasmids
New Plasmid Isolation of theBackbone Fragment
Isolation of the
Insert Fragment
delCMV-mCherry Double Digestion (AseI, BsrGI) of pmCherry-N1
Double Digestion (AseI, BsrGI) of 
delCMV-mCherry-actin
delCMV-mCherry-PAK-GBD Double Digestion (BamHI, EcoRI) of delCMV-mCherry-actin
PCR amplification of the PAK 
GBD (template = pΔSV40-
PakGBD-mCherry, forward primer 
= PAK1_forward, reverse primer = 
PAK1_reverse)
delCMV-mCherry-RBD Double Digestion (BamHI, EcoRI) of delCMV-mCherry-actin
PCR amplification of the Rhotekin 
GBD (template = mCherry-
Rhotekin(8-89)-mCherry-C1, 
forward primer = RBD_forward, 
reverse primer = RBD_reverse)
delCMV-mCherry-rGBD Double Digestion (BamHI, EcoRI) of delCMV-mCherry-actin
PCR amplification of the Rhotekin 
GBD (template = GFP-rGBD, 
forward primer = rGBD_forward, 
reverse primer = rGBD_reverse)
delCMV-mCherry-WASP-GBD Double Digestion (BamHI, EcoRI) of delCMV-mCherry-actin
PCR amplification of the WASP 
GBD (template = pΔSV40-
mCherry-WASP-GBD, forward 
primer = WaspGBD_forward, 
reverse primer = 
WaspGBD_reverse)
delCMV-mCitrine Double Digestion (AseI, BsrGI) of pmCitrine-N1
Double Digestion (AseI, BsrGI) of 
delCMV-mCitrine-RBD
delCMV-EGFP-p67phox (aa1-203) Double Digestion (BamHI, EcoRI) of delCMV-EGFP-DNIC2
PCR amplification of the p67phox 
GBD (template = pGEX-4T-I-
p67phox-aa1-203, forward primer = 
p67phox aa1-203 forward, reverse 
primer = p67phox aa1-203 reverse)
Rac1Q61LΔCAAX-EGFP-
2×FKBP'
Double Digestion (AgeI, NheI-HF) 
of pEGFP-2×FKBP'
PCR amplification of 
Rac1Q61LΔCAAX (template = 
Rac1Q61L, forward primer = 
NheI-Start-Rac, reverse primer = 
Rac-NgoMIV)
EGFP-Rac1Q61LΔCAAX-
2×FKBP'
Double Digestion (BsrGI, XhoI) of 
pEGFP-2×FKBP'
PCR amplification of 
Rac1Q61LΔCAAX (template = 
Rac1Q61L, forward primer = 
BsrGI-Start-Rac, reverse primer = 
Rac-XhoI)
EGFP-2×FKBP'-
Rac1Q61LΔCAAX
Double Digestion (MfeI,XbaI) of 
pEGFP-2×FKBP'
PCR amplification of 
Rac1Q61LΔCAAX (template = 
Rac1Q61L, forward primer = 
XbaI-Start-Rac, reverse primer = 
Rac-Stop-MfeI)
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Table 2.24:  Summary of New Mammalian Expression Plasmids (continued)
New Plasmid Isolation of theBackbone Fragment
Isolation of the
Insert Fragment
delCMV-EGFP-2×FKBP'-
Rac1Q61LΔCAAX
Double Digestion (AseI, BglII) of 
delCMV-EGFP-tubulin
Double Digestion (AseI, BsrGI) of 
EGFP-2×FKBP'-
Rac1Q61LΔCAAX
mTurquoise2-2×FKBP'-
Rac1Q61LΔCAAX
Double Digestion (BsrGI, NheI-
HF) of EGFP-2×FKBP'-
Rac1Q61LΔCAAX
Double Digestion (BsrGI, NheI-
HF) of pmTurquoise2-N1
mTurquoise2-NES-2×FKBP'-
Rac1Q61LΔCAAX
Double Digestion (NheI-HF, XhoI) 
of mTurquoise2-2×FKBP'-
Rac1Q61LΔCAAX
PCR amplification of 
mTurquoise2-NES (template = 
pmTurquoise2-NES, forward 
primer = NheI-linker, reverse 
primer = NES-BsrGI)
mTurquoise2-NES-2×FKBP'-
Cdc42Q61LΔCAAX
Double Digestion (MfeI, XbaI) of 
mTurquoise2-NES-2×FKBP'-
Rac1Q61LΔCAAX
PCR amplification of 
Cdc42Q61LΔCAAX (template = 
pcDNA3-EGFP-Cdc42Q61L, 
forward primer = XbaI-Cdc42, 
reverse primer = Cdc42-S-Stop)
mTurquoise2-NES-2×FKBP'-
RhoAQ63LΔCAAX
Double Digestion (MfeI, XbaI) of 
mTurquoise2-NES-2×FKBP'-
Rac1Q61LΔCAAX
PCR amplification of 
RhoAQ63LΔCAAX (template = 
pcDNA3-EGFP-RhoA-Q63L, 
forward primer = FW-XbaI-RhoA-
Q63L, reverse primer = RhoA-S-
Stop2)
mTurquoise2-NES-2×FKBP' Double Digestion (NheI-HF, XhoI) of pEGFP-2×FKBP'
Double Digestion (NheI-HF, XhoI) 
of mTurquoise2-NES-2×FKBP'-
Rac1Q61LΔCAAX
delCMV-mTurquoise2-2×FKBP'-
Rac1Q61LΔCAAX
Double Digestion (BsrGI, NheI-
HF) of delCMV-EGFP-2×FKBP'-
Rac1Q61LΔCAAX
Double Digestion (BsrGI, NheI-
HF) of pmTurquoise2-N1
delCMV-mTurquoise2-NES-
2×FKBP'-Rac1Q61LΔCAAX
Double Digestion (NheI-HF, XhoI) 
of delCMV-mTurquoise2-
2×FKBP'-Rac1Q61LΔCAAX
PCR amplification of 
mTurquoise2-NES (template = 
pmTurquoise2-NES, forward 
primer = NheI-linker, reverse 
primer = NES-BsrGI)
delCMV-mTurquoise2-NES-
2×FKBP'-Cdc42Q61LΔCAAX
Double Digestion (Mlu, BsrGI) of 
delCMV-mTurquoise2-NES-
2×FKBP'-Rac1Q61LΔCAAX
Double Digestion (MluI, BsrGI) of 
mTurquoise2-NES-2×FKBP'-
Cdc42Q61LΔCAAX
delCMV-mTurquoise2-NES-
2×FKBP'-RhoAQ63LΔCAAX
Double Digestion (Mlu, BsrGI) of 
delCMV-mTurquoise2-NES-
2×FKBP'-Rac1Q61LΔCAAX
Double Digestion (MluI, BsrGI) of 
mTurquoise2-NES-2×FKBP'-
RhoAQ63LΔCAAX
delCMV-mTurquoise2-NES-
2×FKBP'
Double Digestion (AseI, BsrGI) of 
delCMV-mTurquoise2-NES-
2×FKBP'-Rac1Q61LΔCAAX
Double Digestion (AseI, BsrGI) of 
mTurquoise2-NES-2×FKBP'
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Table 2.24:  Summary of New Mammalian Expression Plasmids (continued)
New Plasmid Isolation of theBackbone Fragment
Isolation of the
Insert Fragment
delCMV-mTurquoise2-NES-PA-
Rac1Q61L
Double Digestion (MfeI, XhoI) of 
delCMV-mTurquoise2-NES-
2×FKBP'-Rac1Q61LΔCAAX
PCR Amplification of PA-
Rac1Q61L (template = mCerulean-
PA-Rac1Q61L, forward primer = 
Xho-linker, reverse primer = MfeI-
linker)
A small amount (1-5 μL) of the ligation solution was used to transform competent E. coli cells (Table 
2.25).
Table 2.25:  Heat Shock Protocol for Transforming Competent E. coli cells.
Step Description
1. Pre-warm an LB agar plate (with the appropriate antibiotic) in the 37°C incubator.
2. Add 1-5 μL of the ligation to competent E. coli cells and thaw the cells on ice for ~10 min.
3. Incubate the cells at 42°C for 2 min.
4. Cool the cells on ice for 2 min.
5. Add 1 mL of sterile LB medium to the cells.
6. Shake the cells at 37°C for ~1 hour.
7. Centrifuge the cells at 5000 rpm for 5 min.  Discard most of the supernatant.
8. Use the remainder of the supernatant to re-suspend the cells.
9. Plate the cells on the pre-warmed LB agar plate.
10. Incubate the LB agar plate overnight at  37°C.
Individual colonies (typically 3-6) were selected from the LB agar plate for further characterization. 
Each colony was used to inoculate 5 mL of sterile Luria-Bertani (LB) medium containing the 
appropriate antibiotic (e.g., ampicillin or kanamycin).  The inoculated cultures were incubated 
overnight at 37°C with shaking.  For each of the overnight cultures, a glycerol stock solution was 
prepared by combining 700 μL of the overnight culture and 300 μL of sterile 50% glycerol.  The 
glycerol stock solutions were stored at -80°C.  Plasmid DNA was isolated from the remainders of each 
of the overnight cultures using a QIAprep Spin Miniprep Kit (Qiagen).
Plasmid DNA was subjected to sequencing analysis (Table 2.26 and Table 2.27).
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Table 2.26:  Preparing Plasmid DNA for Sequencing Analysis
Component Volume Initial Concentration Final Concentration
Plasmid DNA 0.5 μL 0.500 μg/μL 0.025 μg/μL
Sequencing Primer 0.5 μL 10 μM 0.5 μM
Nuclease-free Water 7.0 μL - -
Big Dye Terminator Mix 2.0 μL - -
Table 2.27:  PCR Program Used for Sequencing
Repetitions T (°C) Time (sec)
1 96 30
25
96 30
50 15
60 240
1 8 ∞
2.2.4 Live and Fixed Cell Imaging
Widefield images of the fixed and stained cells of the neurite outgrowth screens were obtained on an 
Olympus IX81 microscope equipped with a 10x objective and a Hamamatsu ORCA ER C4742-80-
12AG Camera. Light for excitation of the fluorophores was produced with an MT20 light source 
(Olympus). The procedure of image acquisition was automated with the ScanˆR software (Olympus).  
For each well of the plate, images were taken at 6 positions.  For each position, images were taken of 
the nuclei (DAPI), the microtubules (RFP), and the actin filaments (GFP).
Widefield and Total Internal Reflection Fluorescence (TIRF) images of live or fixed N2a cells were 
obtained on an Olympus IX81F-3 microscope equipped with a 60x objective and a Hamamatsu Image 
EM CCD-C9100-13 Camera. Light for excitation of the fluorophores was produced with an MT20 light 
source (Olympus). For certain photoactivation experiments, neutral density filters from Thor Labs 
(NDUV510B, NDUV520B, and NDUV530B) were used to reduce the intensity of light produced by 
the MT20. For TIRF images, four lasers (405 nm, 445 nm, 488 nm/514 nm, and 561 nm) were used to 
selectively excite fluorphores within a limited distance (90-200 nm) of the glass substrate. The 
procedure of image acquisition was automated with the CellˆR software (Olympus). For live cell 
imaging, the N2a medium was removed and replaced with warm imaging medium [10% v/v FBS 
(PAN-Biotech), 90% v/v DMEM (PAN-Biotech)] prior to imaging.
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Confocal images of fixed N2a cells were obtained on an LSM 510 Meta microscope equipped with a 
40x objective. Light for excitation of the fluorophores was produced with an LSM 510 Laser Module 
(Zeiss). The procedure of image acquisition was automated with the LSM Software (Zeiss).
2.2.5 Software
The following software was used for data analysis and preparation of figures.
Table 2.28:  Software
Name Organization(s)
ApE (A plasmid Editor) University of Utah
CellProfiler37 Broad Institute
ImageJ38 National Institutes of Health (NIH)
NeuriteQuant39
Max-Planck-Institute (MPI) of Molecular Physiology, Dortmund 
University of Technology, University of California, San Diego (UCSD)
National Chiao Tung University
Office (Excel, Word, PowerPoint) Microsoft
Paint Microsoft
PRISM GraphPad
3. RESULTS
3.1 Neurite Outgrowth Screens and Proliferation Assays
In cells, actin molecules can exist as independent entities or they can combine together to form 
filaments (Fig. 1.2). Interconversion between the monomeric and filamentous forms of actin is crucial 
for proper cellular function.  Interestingly, several natural products that interfere with this 
interconversion have been identified.  Three such molecules are phalloidin, jasplakinolide, and 
chondramide C (Fig. 3.1A).  And, methods for synthetic preparation of these molecules have been 
reported in the literature40-48.  Furthermore, chemists at the Max Planck Institute of Molecular 
Physiology have reported a strategy to synthesize a library of small molecules based on these natural 
products5.
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A
B
C
Figure 3.1:  Small Molecules Used in the Neurite Outgrowth Screens.  (A) Natural 
products known to stabilize actin filaments.  (B) Synthetic analogues of the natural products 
shown in (A).  (C) Structure of taxol.
Synthetic analogues from this library were screened for their ability to perturb actin dynamics.  This 
screen is based upon the idea that disruptions to the balance between protrusive and contractile forces 
associated with microtubules and actin filaments, respectively, can lead to changes in cell 
morphology49-51.  Therefore, each of the compounds was combined with taxol, a natural product known 
to stabilize microtubules52 and added to N2a cells.  Jasplakinolide and chondramide C, which are 
known to induce the formation of neurites in the presence of taxol, were used as positive controls.
53
RESULTS
                                                                                                                                                      
Neurite formation was only observed in the presence of three of the analogues tested (WVA-176, 
LGM174, and LGM235).  And, for two of these analogues (WVA-176 and LGM174), neurites were 
only observed at the two highest concentrations tested (Fig. 3.2A and Fig. 3.2B).  However, cells 
treated with 5 μM LGM174  produced fewer neurites than cells treated with the same concentration of 
WVA-176.  Rather, at 5 μM, LGM174 was more likely to cause the accumulation of actin in the 
perinuclear regions of the cells (Fig. 3.2B).  This effect was still observable at 1.67 μM of LGM174.  
However, when the concentration of LGM174 was reduced to 555.56 nM, this effect was no longer 
prominent (Fig. 3.2B).
LGM235 behaved similar to the positive controls (jasplakinolide and chondramide C), producing 
neurites over a much larger concentration range than WVA-176 or LGM174 (Fig. 3.3A). LGM235 also 
demonstrated similarities to LGM174, since lower concentrations of the compound produced an 
accumulation of actin in the perinuclear region (Fig. 3.3B).  However, for LGM235, this effect was 
observed over a far broader range of concentrations (Fig. 3.3C).  Interestingly, although LGM235 
clearly disrupts normal actin dynamics at lower concentrations, it does not affect cell proliferation at 
these concentrations (Fig. 3.4A).
Fluorescent analogues of LGM235 were synthesized by adding TAMRA or BODIPY moieties to the 
lysine side chain (Fig. 3.4B and Fig 3.4C). These compounds were generated as possible alternatives to 
fluorescently labeled phalloidins that are routinely used to stain actin structures in fixed and 
permeabilized cells.  Both 21C and 21D successfully labeled actin structures in fixed and 
permeabilized cells8.  However, only 21D was capable of staining static, long-lived actin filaments in 
live N2a cells. In contrast to LGM235 (Fig. 3.4A), neither 21C nor 21D impeded cell proliferation at 
high concentrations (Fig. 3.4B and Fig. 3.4C).
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A
15.00 μM WVA-176 5.00 μM WVA-176 1.67 μM WVA-176 555.56 nM WVA-176
B
15.00 μM LGM174 5.00 μM LGM174 1.67 μM LGM174 555.56 nM LGM174
C
15.00 μM jasp. 5.00 μM jasp. 1.67 μM jasp. 555.56 nM jasp.
D
DMSO control  for
15.00 μM conditions
DMSO control  for
5.00 μM conditions
DMSO control  for
1.67 μM conditions
DMSO control for
555.56 nM conditions
Figure 3.2:  Rearrangements of the Actin Cytoskeleton in N2a Cells Induced by 
WVA-176 and LGM174.  These are composite images showing the microtubules (red), 
actin filaments (green), and nuclei (blue) of N2a cells treated with various concentrations 
of WVA-176 (A), LGM174 (B), jasplakinolide (jasp.) (C), or DMSO (D).
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A
B
2.29 nM
LGM235
2.29 nM 
jasplakinolide
2.29 nM
chondramide C
DMSO control for 
2.29 nM conditions
C
84.68 pM
LGM235
84.68 pM
jasplakinolide
84.68 pM
chondramide C
DMSO control for 
84.68 pM conditions
Figure 3.3:  Rearrangements of the Actin Cytoskeleton in N2a Cells Induced by 
LGM235. (A) Heat maps generated by NeuriteQuant39 to highlight conditions where 
neurites were observed. For each concentration, 3 wells of cells were treated with the 
compound and one well was left as a reference (ref).  The arrangement of these 4 wells is 
depicted in the schematic shown on the right. (B and C) Widefield images showing the 
localization of actin in N2a cells treated with 1 µM taxol and LGM235, jasplakinolide, 
chondramide C, or DMSO.
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A
B
C
Figure 3.4: Cell Proliferation of N2a Cells in the Presence of LGM235, 21C, and 21D.  Cells were 
incubated in the presence of LGM235 (A), 21C (B), or 21D (C) for 3 days at 5% CO2 and 37°C. Then, 10 
μL of WST-1 Cell Proliferation Reagent (Roche) was added to each of the wells and the cells were 
incubated for 1.5-2 hours at 5% CO2 and 37°C.  For each well, the absorbance at 450 nm and the 
absorbance at 650 nm was measured.
3.2 TIRF-based Biosensors for Measuring Rho GTPase Activity
Rho GTPases are a group of signaling molecules that regulate various cellular processes. Because of 
their ability to exist in an “on” (GTP-bound) state and an “off” (GDP-bound) state, Rho GTPases are 
frequently referred to as molecular switches. When a Rho GTPase is in the active (GTP-bound) state, it 
can interact with downstream effector proteins. Therefore, since effector proteins selectively bind to the 
active forms of Rho GTPases, they can be used as the basis for the design of Rho GTPase activity 
biosensors.
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The approach used here is similar to previous methods published in the literature29-31 and involves the 
construction of a mammalian expression plasmid that encodes a fluorescent protein linked to the 
GTPase-binding domain (GBD) of an effector protein (Fig. 3.5A). A truncated CMV promoter 
(delCMV)53 was used to ensure that expression of the protein would be weak, thereby minimizing 
disruption of normal cellular processes by the biosensor. Low-level expression of the biosensor should 
also result in a lower background fluorescence signal, making changes in localization of the biosensor 
easier to detect.
Each biosensor should accumulate in regions of the cell where its corresponding Rho GTPase is highly 
active. And, since Rho GTPases such as Rac1, Cdc42, and RhoA are frequently activated by 
membrane-bound GEFs14,18, one would expect the activation of these Rho GTPases to be accompanied 
by recruitment of their corresponding biosensors to the plasma membrane. Total Internal Reflection 
Fluorescence (TIRF) microscopy can be used to monitor this recruitment in the region of the cell 
nearest to the glass substrate (Fig. 3.5B).
A
B
Figure 3.5: TIRF-based Biosensors for Measuring Rho GTPase Activity.  (A) Essential 
features (promoter, fluorescent protein sequence, and GBD sequence) of a mammalian 
expression plasmid that encodes a biosensor. (B) Representation of a cell on a glass substrate. 
When Cdc42 becomes activated at the plasma membrane, it should recruit its corresponding 
biosensor from the cytosol to the plasma membrane. TIRF microscopy, which measures 
fluorescence intensity in the region nearest to the glass substrate, can be used to monitor  
recruitment of the biosensor.
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Two previously published plasmids and new plasmids developed as part of the work described here that 
encode biosensors for measuring Rho GTPase activity are summarized in Table 3.1 and Figure 3.6.
Table 3.1:  Plasmids Encoding TIRF-based Rho GTPase Activity Biosensors
Plasmid Name Description of the GBD Corresponding Rho GTPase
pΔSV40-mCherry-WASP-GBD WASP (amino acids 201-231) Cdc42
pΔSV40-PAK-GBD-mCherry PAK1 (amino acids 67-129) Rac1/Cdc42
delCMV-mCherry-WASP-GBD WASP (amino acids 201-231) Cdc42
delCMV-mCherry-PAK-GBD PAK1 (amino acids 67-129) Rac1/Cdc42
delCMV-mCherry-RBD Rhotekin (amino acids 8-89) RhoA
delCMV-mCherry-rGBD Rhotekin (amino acids 7-89) RhoA
delCMV-EGFP-p67phox-aa1-203 p67phox (amino acids 1-203) Rac1
delCMV-mCherry - -
delCMV-mCitrine - -
Figure 3.6:  Essential Features of Plasmids Encoding TIRF-based Biosensors for 
Measuring Rho GTPase Activity.  This figure highlights the differences between the plasmids 
encoding the biosensors: promoter, fluorescent tag, GBD, and corresponding Rho GTPase(s).
59
RESULTS
                                                                                                                                                      
3.3 Acute Photoactivation of Rac1
3.3.1 Photoactivation of Rac1 Induces Lamellipodia Formation in N2a Cells
Phototropins are a class of protein kinases that become activated upon exposure to light. These proteins 
are sometimes referred to as light switches, since they adopt one conformation in the dark and another 
conformation when they are illuminated with light of an appropriate wavelength.
In phototropin1, the kinase domain is located next to a light-oxygen-voltage 2 (LOV2) domain that acts 
as a photosensor. NMR studies suggest that the LOV2 domain sterically blocks the kinase domain in 
the “dark” state and that light leads to structural rearrangements that remove this steric block. In 
particular, a Jα helix at the C-terminus of the LOV2 domain appears to unravel in the “lit” state54-56.
A B
C
Before photoactivation
(TIRF red fluorescence)
After photoactivation
(TIRF red fluorescence)
Figure 3.7:  Acute Photoactivation of Rac1 Induces Lamellipodia Formation in N2a 
Cells.   (A) Cartoon illustrating the proposed conformational change that PA-Rac1 undergoes 
upon exposure to light.  In the “dark” state, the LOV2 domain sterically blocks Rac1 from 
interacting with downstream effector proteins, such as PAK1.  However, upon illumination, 
the Jα helix unravels and releases the Rac1, allowing it to bind to its downstream effector 
proteins.  (This figure was taken from reference 57).  (B) Absorption spectrum of the LOV2 
domain from Avena sativa phototropin1 (This figure was taken from reference 58).  (C) N2a 
cells expressing PA-Rac1-Venus and mCherry before (left) and after (right) photoactivation 
[63 (1-sec.) pulses of blue light (~420-434 nm) applied at 4-sec. Intervals].  Acute 
photoactivation of Rac1 produced lamellipodia at the periphery of many cells.
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Wu et al. have proposed that the LOV2 domain can be used to “cage” other proteins so that their 
behavior can be controlled by exposure to light. As an example of this, they fused the LOV2 domain 
from Avena sativa (oat) phototropin1 to the N-terminus of a human Rac1 mutant35 (Fig. 3.7A). This 
fusion protein was referred to as photoactivatable Rac1 (PA-Rac1). Unlike wild-type Rac1, where 
activity is determined by the state of the bound nucleotide (GTP or GDP), the activity of PA-Rac1 
should be solely determined by the conformation of the adjacent LOV2 domain.  Therefore, a Q61L 
mutation was introduced to lock Rac1 in the active state and to lower its affinity for RhoGDI and for 
GEFs. Also, E91H and N92H mutations were introduced to reduce the likelihood that PA-Rac1 would 
sequester GAPs and indirectly activate endogenous Rac1 proteins.
The LOV2 domain absorbs light over a very broad range of wavelengths58 (Fig. 3.7B), including those 
typically used to excite blue, cyan, and green fluorescent proteins. Wu et al. also warn that certain 
wavelengths that are used to excite yellow fluorescent proteins might also be capable of activating PA-
Rac157. Based on this information, studies involving acute photoactivation of Rac1 were performed 
primarily in combination with red fluorescent proteins, such as mCherry. As a further precaution, to 
minimize pre-activation, cells were transferred to foil-covered containers immediately after transfection 
and great care was taken to avoid exposing the cells to light prior to microscopy experiments.
As a preliminary experiment, N2a cells expressing a Venus-labeled PA-Rac1 and mCherry were 
exposed to 1 second pulses of blue light (~420-434 nm) at 4 second intervals. After ~5 minutes of this 
photoactivation protocol, many cells developed lamellipodia (Fig. 3.7C), a phenotype commonly 
observed upon activation of Rac1.
3.3.2 Optimization of a Reversible Photoactivation Protocol
Wu et al. report that photoactivation is a reversible process, with a dark recovery half-life of ~43 
seconds35.  Therefore, a reversible photoactivation protocol was developed (Fig. 3.8A) consisting of 
three phases: “pre-activation”, “photoactivation”, and “post-activation”.  Throughout all three phases, 
red TIRF images were acquired at 5 second intervals.  However, during the “photoactivation” phase of 
the protocol, the cells were constantly illuminated with blue light in between these intervals.  Constant 
blue light illumination was used instead of pulses to minimize dark recovery between TIRF 
measurements.
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A
B
C
Figure 3.8:  Responses of Previously Published Biosensors to Reversible Photoactivation 
of Rac1. (A) Cartoon illustrating the protocol used to reversibly photoactivate Rac1. 
Throughout all 3 phases of the protocol (“pre-activation”, “photoactivation”, and “post-
activation”), red TIRF images were acquired at 5 second intervals.  However, during the 
“photoactivation” phase of the protocol, the cells were constantly illuminated with blue light 
in between these intervals. (B) Graph showing the changes in red TIRF intensity that were 
observed when an N2a cell expressing PA-Rac1 and the previously published WASP 
biosensor was subjected to the protocol shown in (A).  (C) Plot comparing the relative % 
changes observed for different experimental conditions.  Cells expressing the previously 
published WASP biosensor showed a dramatic increase in intensity upon photoactivation of 
Rac1.  Conversely, cells expressing the previously published PAK1 biosensor or mCherry 
(control) did not show any significant changes in intensity upon photoactivation of Rac1. 
Biosensor recruitment was also not observed in control experiments where a constitutively 
active Rac1 mutant (Rac1Q61L) was substituted for PA-Rac1 or where PA-Rac1 was 
omitted.  (Note: For these experiments, the level of FBS in the medium was lowered to 2% 
approximately 4 hours after transfection.  However, similar results were observed when this 
step was omitted).
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This protocol was used to test the effect of acute photoactivation of Rac1 on the localization of 2 
previously published Rho GTPase biosensors (Fig. 3.6)29. One of these biosensors was based on the 
GBD of PAK1, which binds to both active Rac1 and active Cdc42.  The other biosensor was based on 
the GBD of WASP, which only binds to active Cdc42.  Each of these biosensors was encoded by a 
plasmid containing a truncated SV40 promoter (ΔSV40) and each of these biosensors was labeled with 
mCherry.
Relative % change in TIRF intensity of the biosensor upon photoactivation of Rac1 was used to 
measure the extent of recruitment of the biosensor to the plasma membrane.
relative % change = 
IPA – I0
× 100
I0
In this equation, IPA represents the average, background subtracted, TIRF intensity of the biosensor 
within a cell during initial photoactivation and I0 represents the average, background subtracted, TIRF 
intensity of the biosensor within a cell immediately prior to photoactivation (Fig. 3.8A).
Photoactivation of Rac1 led to recruitment of the WASP biosensor to the plasma membrane (Fig. 3.8B 
and Fig. 3.8C). This suggests that activation of Rac1 leads to activation of Cdc42, which is consistent 
with other published data59. Furthermore, after photoactivation, the intensity of this biosensor quickly 
returned to a value that was similar to that observed prior to photoactivation, demonstrating that 
activation of Cdc42 is reversible.
Photoactivation of Rac1 did not lead to recruitment of the PAK1 biosensor (Fig. 3.8C).  This result was 
surprising, since PAK1 has been shown to bind to active Rac1. However, Wu et al. report that they 
were not able to directly measure binding between PA-Rac1 and PAK1, since measurements performed 
under ambient light (“room light”) conditions produced inconsistent results57.  Instead, they generated 
“dark” and “lit” mutants of PA-Rac1 in order to estimate the binding affinities of PAK1 for PA-Rac1 in 
these two states57.  Nevertheless, experiments with the WASP (Fig. 3.8B and 3.8C) suggest that 
photoactivation of Rac1 leads to activation of Cdc42.  So, even if the PAK1 biosensor is unable to bind 
directly to PA-Rac1, it should be recruited to the plasma membrane by the activated Cdc42. However 
this was not observed. Therefore, only the WASP biosensor was selected for use in experiments to 
optimize the reversible photoactivation protocol.
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A
B
C
Figure 3.9:  Optimization of the Reversible Photoactivation Protocol.  All experiments 
shown here were performed with N2a cells Expressing a Venus-labeled PA-Rac1 and the 
previously published WASP biosensor (Fig. 3.6).  (A) Comparison of results obtained when 
photoactivation and measurements of recruitment were performed using different filter cubes 
(left) or the same filter cube (right).  The modified protocol (right) produces less noise during 
the photoactivation phase without affecting the magnitude of the relative % change.  (B) 
Light titrations using “10X” and “100X” neutral density filters.  In these experiments there is 
no correlation between the intensity of blue light and the level of biosensor recruitment. (C) 
Light titrations using a “1000X” neutral density filter.  In these experiments, increasing the 
intensity of the blue light leads to increases in the level of biosensor recruitment.
First, attempts were made to reduce the noise that appears during the photoactivation phase of the 
protocol (Fig. 3.8B and Fig. 3.9A). It was reasoned that this noise might come from the repetitive 
switching from a CFP/YFP filter cube (for global photoactivation) to a TripleTIRF filter cube (for 
monitoring recruitment of the biosensor) and back again; imperfect repositioning of the filters caused 
by this repetitive switching might lead to variations in the TIRF intensity. Therefore, the protocol was 
modified so that the TripleTIRF filter cube was used for both of these processes. There was a 
possibility that this modification would reduce the intensity of the blue light to a level that would no 
longer produce photoactivation. However, the modified protocol produced relative % changes similar
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to those observed with the original protocol while simultaneously reducing the noise that appeared with 
the original protocol (Fig. 3.9A).
Light titrations were also performed to determine whether the level of biosensor recruitment could be 
controlled by varying the intensity of the blue light.  Initial attempts to modulate the level of 
photoactivation using NDUV510B and NDUV520B neutral density filters (Thor Labs), which reduced 
the intensity of the light by 10-fold and 100-fold, respectively, were unsuccessful (Fig. 3.9B).  Rather, 
the level of biosensor recruitment remained relatively constant during these experiments, suggesting 
that even the minimum dose of light tested was sufficient to produce the maximum level of 
photoactivation. However, light titrations performed with the NDUV530B neutral density filter (Thor 
Labs), which reduced the intensity of the light by 1000-fold, showed a clear correlation between the 
intensity of the light used and the level of biosensor recruitment (Fig. 3.9C).
All subsequent photoactivation experiments were performed using an optimized protocol that included 
using the NDUV530B neutral density filter (Thor Labs) to reduce the intensity of the blue light.  
Furthermore, in this optimized protocol, a single filter cube (TripleTIRF) was used for both 
photoactivation and for monitoring recruitment of the biosensor.
3.3.3 Comparison of TIRF-based Biosensors Used to Measure Rac1 Activity
It is important to note that the GBD of PAK1 binds to both active Rac1 and active Cdc42.  
Consequently, biosensors based on this GBD will not be able to distinguish between these two Rho 
GTPases.  Therefore, a new biosensor (delCMV-mCherry-p67phox-GBD) based on the GBD of p67phox, 
which selectively binds to active Rac1, was prepared by Djamschid Solouk (a Master's student under 
my supervision)32.
For comparison, a new PAK1-based biosensor (delCMV-mCherry-PAK-GBD) was also prepared.  
There are two important features that distinguish the new PAK1-based biosensor from the previously 
published PAK1-based biosensor (Fig. 3.6).  First, the plasmid encoding the new biosensor has a 
delCMV promoter to ensure low-level expression of the protein.  Second, for the new biosensor, the 
fluorescent tag (mCherry) is fused to the N-terminus of the GBD, rather than the C-terminus.
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A
B
C
Figure 3.10:  Comparison of Biosensors Used to Measure Rac1 Activity.  N2a cells 
expressing PA-Rac1 and a biosensor were subjected to the optimized reversible 
photoactivation protocol.  (A) On average, the new Rac1 biosensor (delCMV-mCherry-
p67phox-GBD) produced the largest relative % change, the previously published Rac1/Cdc42 
biosensor (pΔSV40-PAK-GBD-mCherry) produced the smallest relative % change, and the 
new Rac1/Cdc42 biosensor (delCMV-mCherry-PAK-GBD) produced an intermediate value. 
However, the new Rac1/Cdc42 biosensor also produced the largest range of values, including 
negative values that were larger in magnitude than those observed for the other conditions.  
Graphs of N2a cells expressing PA-Rac1 and the new Rac1 biosensor (B) or the new 
Rac1/Cdc42 biosensor (C) are shown for comparison to each other.
The optimized reversible photoactivation protocol was used to examine the responses of different 
biosensors used to measure Rac1 activity (Fig. 3.10A).  Consistent with the data shown in Figure 3.8C, 
the previously published PAK1 biosensor (pΔSV40-PAK-GBD-mCherry) showed the weakest response 
to photoactivation of Rac1. On average, the biosensor based on the GBD of p67phox (delCMV-mCherry-
p67phox-GBD) showed the largest relative % change in response to reversible photoactivation of Rac1
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(Fig. 3.10A and Fig. 3.10B). And, the new PAK1-based biosensor (delCMV-mCherry-PAK-GBD) 
showed an average relative % change intermediate between the other two biosensors.  However, this 
biosensor also produced the broadest range of values, including negative values that were larger in 
magnitude than those observed with the other biosensors (Fig. 3.10C).
3.3.4 Measuring the Crosstalk Between Rac1, Cdc42, and RhoA
In addition to the published Cdc42 biosensor (pΔSV40-mCherry-WASP-GBD) and the new Rac1 
biosensor (delCMV-mCherry-p67phox-GBD) described above, a new RhoA biosensor (delCMV-
mCherry-RBD), based on the Rhotekin GBD (RBD), was developed as part of the work described here. 
And, light titrations similar to those shown in Figure 3.9C were used to examine the responses of these 
three biosensors to acute photoactivation of Rac1 in N2a and HeLa cells32.
On average, each of the biosensors showed an increase in activity of the corresponding GTPase upon 
acute photoactivation of Rac1 (Fig. 3.11 and Fig. 3.12). This was somewhat surprising, since there have 
been many studies showing that activation of Rac1 leads to inhibition of RhoA26.  However, closer 
inspection of the data revealed that one of the N2a cells did indeed show a decrease in RhoA activity 
upon acute photoactivation of Rac1 (Fig. 3.13A).  Interestingly, this was not observed for experiments 
with HeLa cells.  Similarly, Wu et al. noted that MEF, HEK293, and HeLa cells displayed different 
responses to photoactivation of Rac135.  And, they concluded that the pathways that regulate these 
responses may vary among different cell lines35.  However, the data shown here also suggest that the 
crosstalk between Rac1 and RhoA may vary within a population of N2a cells.
In a series of experiments performed by, Aline Timmermann (another Master's student under my 
supervision) N2a cells expressing PA-Rac1 and the RhoA biosensor were exposed to three short pulses 
of 100% blue light at two time point (0 hrs and 9.5 hrs)60.  The results of these experiments were 
similar to those shown in Figure 3.11, with the majority of cells showing an increase in RhoA activity 
upon photoactivation of Rac1.  However, a small number of cells showed a decrease in RhoA activity 
upon photoactivation of Rac1.  Cells expressing high levels of PA-Rac1 or moderate to high levels of 
the biosensor were more likely to show a decrease in RhoA activity (Fig. 3.13B). Surprisingly, one of 
these cells actually changed its behavior over time (Fig. 3.13C).  However, this appears to be a rare 
occurrence. 
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Figure 3.11:  Measurement of Rac1, Cdc42, and RhoA Activities in Response to 
Photoactivation of Rac1.  Cells expressing a Venus-labeled PA-Rac1 and one of the 
biosensors or mCherry-N1 (control) were subjected to pulsed light titrations using the 
“1000X” neutral density filter.  For each graph, the number of cells studied (n) is indicated.  
Black lines show the average response for all of the cells studied.  Red lines show the 
average plus (above) or minus (below) one standard deviation.  [These data were acquired 
during the MPI Systems Biology Practical (2012) under the supervision of Djamschid 
Solouk.  Dr. Leif Dehmelt and Dr. Tomàš Mazel oversaw the data analysis.]
The relationship between Rac1 activity and RhoA activity in N2a cells remains unclear.  And, 
alternative approaches to study this relationship (described below) have been developed.
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Figure 3.12:  Blue Light Dose-Response Curves for the Data Shown in Figure 3.11.
A
B
C
Figure 3.13:  Photoactivation of Rac1 Leads to RhoA Inhibition in a Limited 
Number of N2a Cells.  (A) An example from the experiments described in Figure 3.11.  
(B) Graphs showing that cells expressing high levels of PA-Rac1 or moderate to high 
levels of the RhoA biosensor (at 0 hrs) are more likely to show RhoA inhibition upon 
photoactivation of Rac1. (C) Images (above) and graphs (below) of an N2a cell that 
initially showed RhoA inhibition (left) and later activation (right) in response to 
photoactivation of Rac1.  Yellow boxes indicate the regions used to make the graphs.  
[The data in B and C were acquired by Aline Timmermann]
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3.3.5 Localization of PA-Rac1 in N2a and HeLa Cells
Finally, confocal microscopy experiments were performed (by Johannes Koch, a PhD student at the 
University of Duisburg-Essen) to examine the localization of PA-Rac1 in N2a cells.  Surprisingly, a 
large fraction of PA-Rac1 was found to localize to the nuclei of N2a cells (Fig. 3.14A and Fig. 3.14B).  
And, similar results were observed in HeLa cells (Fig. 3.14C and Fig. 3.14D), demonstrating that this 
behavior is not specific to N2a cells.
A B
C D
E F
Figure 3.14:  Localization of PA-Rac1 in N2a and HeLa cells.  (A) Confocal images showing 
the localization of PA-Rac1 in N2a cells.  (B)  Confocal images [corresponding to those in (A)] 
showing the nuclei of N2a cells expressing PA-Rac1. (C) Widefield images showing the 
localization of PA-Rac1 in HeLa cells. (D) Image from a supplementary movie published by Wu 
et al.35 showing the localization of PA-Rac1 in a HeLa cell. (E) Widefield image showing the 
localization of EGFP-Rac1Q61L in N2a cells.  (F) Widefield image [corresponding to the image 
in (E)] showing the nuclei of N2a cells expressing EGFP-Rac1Q61L. (Images in A, B, E, and F 
were provided by Johannes Koch.  Images in C were provided by Djamschid Solouk)
This behavior is very different from that typically observed for wild-type Rac1, which is predominantly 
found in the cytosol in complex with RhoGDI21.  However, the Q61L mutation in PA-Rac1 greatly 
reduces its affinity for RhoGDI35.  Nevertheless, the nuclear localization of PA-Rac1 does not appear to 
be related to the Q61L mutation, since EGFP-Rac1Q61L was not usually observed in the nuclei of N2a 
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cells (Fig. 3.14E and Fig. 3.14F).
Wild-type Rac1 also undergoes post-translational prenylation, which allows it to interact with 
membranes.  And, since no mutations were made to PA-Rac1 to prevent this modification, PA-Rac1 
might also be expected to localize to membranes.  And, indeed, PA-Rac1 does appear to localize to the 
plasma membrane (Fig. 3.14A).  However, it is unclear why a significant fraction of PA-Rac1 is also 
found in the nucleus.
It is worth noting that the nuclei of N2a cells expressing PA-Rac1 appear to be deformed (Fig. 3.14B), 
suggesting that PA-Rac1 can interfere with normal cellular function, even in the absence of blue light. 
This effect appears to be related to the Q61L mutation, since N2a cells expressing EGFP-Rac1Q61L 
frequently displayed the same phenotype (Fig. 3.14F).  Furthermore, Wu et al. report that they also 
observed residual pre-activation of PA-Rac1 in the dark and they propose different methods to reduce 
this effect by optimizing the expression level of PA-Rac1.
3.3.6 Design and Preparation of an Optimized PA-Rac1
Based on the observations described above, a new photoactivatable Rac1 construct was designed and 
prepared.  The plasmid for this construct (delCMV-mTurquoise2-NES-PA-Rac1Q61L) has a delCMV 
promoter to ensure low-level expression of the protein.  This should minimize disruption of normal 
cellular processes by PA-Rac1.  It may also minimize residual pre-activation of PA-Rac1 in the dark.  
Furthermore, since previous experiments showed that the response of the RhoA biosensor depends 
upon the level of PA-Rac1 (Fig. 3.13B), experiments with this new construct might help to clarify the 
relationship between Rac1 activity and RhoA activity in N2a cells. A nuclear export sequence (NES)36 
was also added between the fluorophore and the LOV2 domain to prevent accumulation of PA-Rac1 
within the nucleus.
Preliminary experiments have shown that this optimized PA-Rac1 localizes primarily to the plasma 
membrane (Fig. 3.15). And, the nuclear deformations observed with the original PA-Rac1 construct 
appear largely absent in N2a cells expressing the new PA-Rac1 construct.
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Figure 3.15:  Localization of an Optimized PA-Rac1 in N2a cells. 
N2a cells expressing an optimized PA-Rac1 were fixed and confocal 
images of these cells were taken.
3.4 Recruitment of Active Rho GTPases to the Plasma Membrane
3.4.1 A Novel Bioorthogonal and Reversible CID System
The approach described by Wu et al. to photoactivate Rac1 has many attractive features.  For example, 
this approach is relatively simple to implement.  Also, photoactivation of Rac1 is rapid and reversible 
(Fig. 3.8B).  Furthermore, the amount of light required to activate PA-Rac1 is extremely small (Fig. 
3.9C).
However, this approach also suffers from certain limitations. For example, because the LOV2 domain 
absorbs light over a very broad range of wavelengths, including those typically used to excite blue, 
cyan, and green fluorescent proteins, these proteins cannot be monitored without activating PA-Rac1. 
Also, unlike wild-type Rac1 or the Rac1Q61L mutant, PA-Rac1 frequently localizes to the nuclei of 
N2a and HeLa cells (Fig. 3.14).  Moreover, expression of PA-Rac1 often induces nuclear deformations, 
even in the absence of blue light (Fig. 3.14).
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It should be noted here that Wu et al. also prepared a photoactivatable Cdc42 construct (PA-Cdc42)35.  
However, an additional mutation (F56W) had to be introduced in Cdc42 in order to stabilize the caged 
conformation of PA-Cdc4235 .  Although this mutation lowered the affinity of PA-Cdc42 for the PAK1 
effector protein in the dark state35 , it is unclear whether this mutation also affects Cdc42 function in 
other ways.  According to Wu et al., photoactivation of this construct in HEK293 and HeLa cells led to 
the formation of filopodia35.  However, photoactivation experiments with this construct, performed as 
part of the work described here, did not lead to membrane recruitment of the biosensors described 
above or to morphological changes in N2a cells (data not shown).
It should also be noted that, although the PA-Rac1 and PA-Cdc42 constructs were originally reported 
over 4 years ago35, Wu et al. have not developed a photoactivatable RhoA construct.  This may suggest 
that their approach is not easily applied to other Rho GTPases.
In light of these observations, an alternative approach to control Rho GTPase activity, based on 
chemically induced dimerization (CID) was developed.  In this approach, a small molecule (referred to 
as a “dimerizer”) binds simultaneously to two distinct protein modules to form a heterodimeric protein 
complex. The dimerizer presented here was designed (by members of Dr. Yaowen Wu's group at the 
Chemical Genomics Centre of the Max Planck Society) to contain one moiety (SLF') that binds to the 
F36V mutant of FKBP (FKBP') and another moiety (TMP) that binds to E. coli dihydrofolate reductase 
(eDHFR) (Fig. 3.16A).  These two protein modules were selected because neither is endogenous to 
mammalian cells.  Therefore, unlike other dimerizers (e.g., rapamycin), SLF'-TMP should not interact 
with endogenous proteins (e.g., wild-type FKBPs) or produce off-target effects.
Aliquots of dimerizer (Fig. 3.16A), competitor (Fig. 3.16B), and two mammalian expression plasmids, 
one encoding a fusion protein consisting of EGFP linked to two copies of the FKBP' module (pEGFP-
2×FKBP') and another encoding a fusion protein consisting of TagBFP  linked to two copies of the 
eDHFR module and the C-terminal plasma membrane targeting sequence of K-Ras (TagBFP-
2×eDHFR-CAAX), were provided by Dr. Yaowen Wu.  N2a cells were transfected with both of these 
plasmids and the dimerizer (SLF'-TMP) was added to the cells, producing rapid recruitment of EGFP-
2×FKBP' to the plasma membrane (Fig. 3.16C).  Subsequent addition of the competitor (TMP) 
produced rapid dissociation of EGFP-2×FKBP' from the plasma membrane (Fig. 3.16C).  A cartoon 
summarizing these observations is shown in Figure 3.16D.
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Figure 3.16:  A Novel Bioorthogonal and Rapidly Reversible CID system.  (A) Structure 
of the dimerizer.  (B) Structure of the competitor.  (C) An N2a cell expressing TagBFP-
2×eDHFR-CAAX and EGFP-2×FKBP' was treated with 10 μM SLF'-TMP, causing rapid 
recruitment of EGFP-2×FKBP' to the plasma membrane.  Subsequent addition of 10 μM 
TMP caused rapid dissociation of EGFP-2×FKBP' from the plasma membrane.  (D) A 
cartoon summarizing the experiment shown in (C)
3.4.2 Recruitment of Constitutively Active Rac1 to the Plasma Membrane
The reversible CID system presented above can be used to mimic the cycling of Rac1 between the 
cytosol and the plasma membrane (Fig. 1.10).  Therefore, three variants of the original pEGFP-
2×FKBP' plasmid were prepared, each containing a sequence encoding a constitutively active Rac1 
mutant (Rac1Q61L).  The prenylation site of Rac1 was removed from these variants (ΔCAAX), in 
order to allow the localization of these proteins to be controlled using the CID system described above 
(Fig. 3.17B and Fig. 3.17C).
Although each of the fusion proteins shown in Figure 3.17C was successfully recruited to the plasma 
membrane using the CID system described above, only the proteins with the Rac1 mutant at the N-
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terminus or the C-terminus produced lamellipodia in response to recruitment (Fig. 3.17D).  Of these 
two proteins, lamellipodia formation was most frequently observed with the variant containing the 
Rac1 mutant at the C-terminus (EGFP-2×FKBP'-Rac1Q61LΔCAAX) (Fig. 3.17D).  Moreover, this 
phenotype was rapidly reversed upon addition of competitor (Fig. 3.18).
A B
C
D
Figure 3.17:  Recruiting a Constitutively Active Rac1 to the Plasma Membrane. (A) 
Regulation of wild-type Rac1 activity by GEFs and GAPs. (B) A constitutively active Rac1 
mutant lacking the prenylation site (Rac1Q61LΔCAAX). (C) Three variants of EGFP-
2×FKBP' with Rac1Q61LΔCAAX at the N-terminus (N-term.), between EGFP and the two 
FKBP' domains (middle), or at the C-terminus (C-term.). (D) N2a cells expressing TagBFP-
2×eDHFR-CAAX and one of the proteins shown in (C) or EGFP-2×FKBP' (control) were 
treated with 10 μM SLF'-TMP.  Then, the % of cells that formed lamellipodia was 
determined.  For each condition, the number of cells studied (n) is indicated.
These results suggest that, even though the Rac1 mutant used in these studies is constitutively active, 
the protein must be properly localized within the cell in order to participate in signaling.  This is in
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agreement with other published data22-23.  Furthermore, these results suggest that the approach described 
here can be used to control Rac1 activity in living cells.
Figure 3.18:  Reversible Recruitment of a Constitutively Active Rac1 Mutant to the 
Plasma Membrane Induces Reversible Lamellipodia Formation.  (A) Red TIRF images of 
an N2a cell expressing TagBFP-2×eDHFR-CAAX, mCherry-N1, and EGFP-2×FKBP' (left) 
or EGFP-2×FKBP'-Rac1Q61LΔCAAX (right) at different time points during a reversible 
recruitment experiment. Green arrows indicate regions of reversible lamellipodium formation. 
(B) Changes in green TIRF intensity observed during the reversible recruitment experiments 
shown in (A).(C) Changes in cell adhesion area observed during the reversible recruitment 
experiments shown in (A). [For each of the graphs in (C) and (D), the number of cells studied 
(n) is indicated.  Graphs in (C) and (D) were provided by Dr. Soumya Banerjee.]
3.4.3 Localization of EGFP-2×FKBP'-Rac1Q61LΔCAAX in N2a Cells
Widefield images of N2a cells expressing EGFP-2×FKBP' revealed that a large fraction of this protein 
is localized to the nucleus (Fig. 3.19A).  In fact, this localization was frequently visible in the 
corresponding TIRF images (Fig. 3.19A), making it difficult to determine changes in fluorescence 
intensity at the plasma membrane.  Notably, during CID-based recruitment experiments, addition of 
SLF'-TMP often led to a dramatic redistribution of EGFP-2×FKBP' from the nucleus to the plasma 
membrane (Fig. 3.16C and Fig. 3.19A), suggesting that EGFP-2×FKBP' can rapidly cycle between the 
nucleus and the cytosol.
Constructs containing the Rac1Q61LΔCAAX mutant displayed even higher levels of nuclear 
localization than EGFP-2×FKBP'.  However, during CID-based recruitment experiments, addition of 
the dimerizer did not produce significant changes in nuclear localization of these proteins (Fig. 3.19B).  
This may suggest that cycling between the nucleus and the cytosol is slower for these proteins.  
76
RESULTS
                                                                                                                                                      
A TagBFP-2×eDHFR-CAAX
+
pEGFP-2×FKBP'
B TagBFP-2×eDHFR-CAAX
+
EGFP-2×FKBP'-Rac1Q61LΔCAAX
before dimerizer after dimerizer before dimerizer after dimerizer
C TagBFP-2×eDHFR-CAAX
+
delCMV-EGFP-2×FKBP'-
Rac1Q61LΔCAAX
before dimerizer after dimerizer
Figure 3.19:  Localization of EGFP-2×FKBP' Constructs in N2a Cells.  Widefield (top) 
and TIRF (bottom) images of N2a cells transfected with TagBFP-2×eDHFR-CAAX and 
pEGFP-2×FKBP' (A), EGFP-2×FKBP'-Rac1Q61LΔCAAX (B), or delCMV-EGFP-2×FKBP'-
Rac1Q61LΔCAAX (C) plasmids were taken before (left) and after (right) addition of the 
dimerizer.
Alternatively, it may also suggest that these proteins are actively maintained within the nucleus.  
Occasionally, minor nuclear deformations were observed with these constructs (Fig. 3.19B).  However, 
these deformations were not as frequent nor as pronounced as those observed with PA-Rac1 (Fig. 3.14).
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To examine the effect of expression level on the nuclear localization of EGFP-2×FKBP'-
Rac1Q61LΔCAAX, a new plasmid was prepared (delCMV-EGFP-2×FKBP'-Rac1Q61LΔCAAX) that  
contained a delCMV promoter to ensure low-level expression of the protein.  However, experiments 
with this new plasmid (Fig. 3.19C) produced results similar to those observed with the original plasmid 
(Fig. 3.19B).
3.4.4 Optimization of the Rac1Q61LΔCAAX Construct
In addition to the mCherry biosensors presented here, mCitrine variants of these biosensors have also 
been prepared.  This makes it possible to simultaneously measure two Rho GTPase activities within the 
same cell.  However, these biosensors cannot be used in combination with the recruitment system 
described above, due to the spectral overlap between EGFP and mCitrine.  Therefore, a new version of 
the Rac1Q61LΔCAAX construct, labeled with mTurquoise2, was prepared.  A nuclear export sequence 
(NES)36 was also added between the fluorophore and the two FKBP' domains of this construct to 
prevent accumulation of this protein within the nucleus (Fig. 3.20A).  Notably, the nuclei of N2a cells 
expressing this protein appear similar to those of non-transfected cells (Fig. 3.20A).
This optimized recruitment system can be used in combination with both mCitrine and mCherry 
biosensors (Fig. 3.20B).  And, these experiments are currently in progress.  Preliminary data suggest 
A B
mTurquoise2-NES-2×FKBP'-
Rac1Q61LΔCAAX
Widefield CFP Widefield Nuclei
Figure 3.20:  Optimization of the Rac1Q61LΔCAAX Construct.  (A) Widefield image 
showing the localization of mTurquoise2-NES-2×FKBP'-Rac1Q61LΔCAAX in N2a cells 
(left).  For comparison, a widefield image of the nuclei is shown (right). (B) Emission spectra 
of BFP, CFP, YFP, and RFP.  
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that recruitment of constitutively active Rac1 to the plasma membrane causes increases in Cdc42 and 
RhoA activities (data not shown).  Although these results are similar to those observed with PA-Rac1 
(Fig. 3.11), additional repetitions of these experiments are needed to confirm these results.
3.4.5 Reversible Recruitment of Active Cdc42 and RhoA to the Plasma 
Membrane
In addition to the Rac1Q61LΔCAAX construct described above, analogous constructs for Cdc42 
(Cdc42Q61LΔCAAX) and RhoA (RhoAQ63LΔCAAX) were also prepared.  And, each of these 
constructs was reversibly recruited to the plasma membrane in order to study how the localization of 
these proteins influences cell morphology and the actin cytoskeleton.
A
B
C
Figure 3.21: Changes in Cell Morphology and the Actin Cytoskeleton Induced by Acute 
and Reversible Recruitment of Constitutively Active Rho GTPases to the Plasma 
Membrane.  TIRF images showing rearrangements of the actin cytoskeletons of N2a cells 
induced by acute and reversible recruitment of constitutively active Rho GTPases to the 
plasma membrane.  Recruitment of Rac1Q61LΔCAAX (A) or Cdc42Q61LΔCAAX (B) to the 
plasma membrane led to the formation of actin-rich protrusions at the cell periphery while 
recruitment of RhoAQ63LΔCAAX (C) to the plasma membrane caused cell contraction.  
Addition of competitor caused rapid reversal of these phenotypes.
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As expected, recruitment of constitutively active Rac1 or Cdc42 to the plasma membrane produced 
actin-rich protrusions at the cell periphery (Fig. 3.21A and Fig. 3.21B) and recruitment of constitutively 
active RhoA to the plasma membrane caused cell contraction (Fig. 3.21C).  And, in each case, addition 
of competitor caused rapid reversal of the observed phenotype (i.e., loss of actin-rich protrusions for 
Rac1 and Cdc42 and cell expansion for RhoA).
3.4.6 Long-term Recruitment of Rho GTPases to the Plasma Membrane
Experiments described above showed that acute and reversible recruitment of constitutively active  
mutants of Rac1, Cdc42, or RhoA to the plasma membrane resulted in acute and reversible changes in 
cell morphology and the actin cytoskeleton (Fig. 3.21).  However, it was not clear whether similar 
results would also be observed for long-term recruitment experiments.  Moreover, for the experiments 
described above, the prenylation sites of Rac1, Cdc42, and RhoA were removed so that each of these 
proteins could be recruited to the plasma membrane using CID.  Therefore, it was also not clear 
whether long-term recruitment experiments would produce results similar to those observed with 
overexpression of the full-length constitutively active forms of these three Rho GTPases.
To clarify these matters, N2a cells were first transfected with DNA encoding mCherry-actin and EGFP-
labeled full-length Rac1Q61L, Cdc42Q61L, or RhoAQ63L.  Consistent with the acute recruitment 
results described above (Fig. 3.21), cells overexpressing full-length Rac1Q61L or Cdc42Q61L 
predominantly showed lamellipodia and filopodia at the cell periphery, while cells expressing full-
length RhoAQ63L predominantly formed filopodia (Fig. 3.22A).  Moreover, cells expressing full-
length RhoAQ63L were often smaller than control cells expressing mCherry-actin alone (Fig. 3.22B 
and Fig. 3.22C).  This is consistent with the observation that acute recruitment of RhoAQ63LΔCAAX 
to the plasma membrane led to cell contraction (Fig. 3.21C). Interestingly, the % of cells displaying 
stress fibers was similar for all three of the full-length Rho GTPases (Fig. 3.22A).
Next, N2a cells expressing mCherry-actin, mCitrine-N1, TagBFP-2×eDHFR-CAAX, and one of the 
mTurquoise2-labeled Rho GTPase constructs described above were incubated overnight in the presence 
or the absence of dimerizer.  When these long-term “recruitment” experiments were performed without 
dimerizer, the cells behaved similar to control cells expressing mCherry-actin alone (Fig. 3.22A and 
Fig. 3.23A).  However, when these experiments were repeated in the presence of dimerizer, cells 
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A
B
mCherry-actin + RhoAQ63L
C
mCherry-actin (control)
Figure 3.22: Changes in Cell Morphology and the Actin Cytoskeleton Induced by 
Overexpression of Full-length Constitutively Active Rho GTPases.  (A) N2a cells 
overexpressing mCherry-actin and EGFP-labeled full-length Rac1Q61L, Cdc42Q61L, or 
RhoAQ63L were observed using TIRF microscopy.  N2a cells overexpressing mCherry-actin 
alone were used as controls.  Cells overexpressing full-length Rac1Q61L or Cdc42Q61L 
predominantly showed lamellipodia and filopodia at the cell periphery, while cells expressing 
full-length RhoAQ63L predominantly formed filopodia.  Interestingly, the % of cells 
displaying stress fibers was similar for all three of the full-length Rho GTPases.  For each 
condition, the number of cells studied (n) is indicated.  (B) TIRF image of N2a cells 
expressing mCherry-actin and EGFP-labeled full-length RhoAQ63L.  (C) TIRF image of 
N2a cells expressing mCherry-actin alone (control).
expressing the RhoAQ63LΔCAAX construct tended to be smaller than cells expressing this construct 
in the absence of dimerizer (Fig. 3.23C and Fig. 3.23D).  These results were similar to those observed 
during short-term recruitment of RhoAQ63LΔCAAX to the plasma membrane (Fig. 3.21C) and during 
long-term overexpression of full-length RhoAQ63L (Fig. 3.22B and Fig. 3.22C).  Furthermore, long-
term recruitment of Rac1Q61LΔCAAX or Cdc42Q61LΔCAAX to the plasma membrane led to an 
increase in lamellipodia formation (Fig. 3.23B).  These results were similar to those observed during 
short-term recruitment of Rac1Q61LΔCAAX and Cdc42Q61LΔCAAX to the plasma membrane (Fig. 
3.21A and Fig 3.21B) and during long-term overexpression of full-length Rac1Q61L and Cdc42Q61L 
(Fig. 3.22A). 
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A
B
C
RhoAQ63LΔCAAX recruitment
(with dimerizer)
D
RhoAQ63LΔCAAX “recruitment”
(without dimerizer)
Figure 3.23:  Changes in Cell Morphology and the Actin Cytoskeleton Induced by 
Long-term Recruitment of Constitutively Active Rho GTPases to the Plasma 
Membrane.  N2a cells expressing mCherry-actin, mCitrine-N1, TagBFP-2×eDHFR-CAAX, 
and one of the mTurquoise2-labeled Rho GTPase constructs described above were incubated 
overnight in the absence (A) or the presence (B) of dimerizer.  (C) TIRF image showing N2a 
cells from the long-term recruitment experiment performed with the RhoAQ63LΔCAAX 
construct in the presence of dimerizer.  (D) TIRF image showing an N2a cell from the long-
term “recruitment” experiment performed with the RhoAQ63LΔCAAX construct in the 
absence of dimerizer.
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Therefore, long-term recruitment experiments produced results similar to those observed during acute 
and reversible recruitment of Rho GTPases to the plasma membrane.  These experiments also produced 
results similar to those observed during overexpression of the full-length Rho GTPases.  However, it 
should be noted that, although a small fraction of cells (14-16%) was observed to form stress fibers 
when the full-length constitutively active Rho GTPases were overexpressed (Fig. 3.22A), stress fibers 
were not observed during the long-term recruitment experiments (Fig. 3.23B).  The reason for this 
remains unclear and further experiments are needed to clarify these results.
4. DISCUSSION
4.1 Natural Products Can Be Used As Templates to Develop Tools to 
Study Actin in Living Cells
Interconversion between the monomeric and filamentous forms of actin is crucial for proper cellular 
function.  For example, during cell division, actin filaments at the leading edge of a motile cell 
disassemble and  reassemble (along with the motor protein myosin) into a structure called the 
contractile ring that separates a mother cell into two daughter cells3.  Similarly, the actin cytoskeleton 
of a white blood cell called a neutrophil must constantly rearrange as this cell searches for bacteria that 
gain access to the body3.
Interestingly, small molecules that disrupt actin dynamics have been isolated from various natural 
sources (Table 1.1)3,5-8.  Three of these molecules (phalloidin, jasplakinolide, and chondramide C) (Fig. 
3.1A) have been shown to bind to and stabilize actin filaments3,5.  In fact, structural studies have shown 
that phalloidin appears to bind to a pocket formed at the interface formed by three subunits of an actin 
filament (Fig. 4.1)61.
Chemists at the Max Planck Institute of Molecular Physiology used this structural information to 
develop a strategy to synthesize a library of small molecules based on phalloidin, jasplakinolide, and 
chondramide C5.  And, these analogues were screened for their ability to disrupt actin dynamics in 
living cells.
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Figure 4.1:  Phalloidin Binds to Actin Filaments at the Interface Formed by Three 
Subunits.  (This figure was taken from reference 61).
At high concentrations, three of these analogues (WVA-176, LGM174, and LGM235) produced results 
similar to those observed with the parent molecules (jasplakinolide and chondramide C) (Fig. 3.2 and 
Fig. 3.3).  However, for two of these analogues (LGM174, and LGM235), a new phenotype was 
observed at intermediate and/or lower concentrations (Fig. 3.2 and Fig. 3.3).  In particular, these 
compounds caused actin to accumulate in the perinuclear region of N2a cells.  Furthermore, additional 
screening experiments have shown that another analogue (LGM163) produces the same phenotype62.
The three analogues that produce this new phenotype share many structural similarities (Fig. 4.2).  In 
fact, LGM174 is simply a TIPS protected analogue of LGM163.  Furthermore, LGM235 and LGM163 
are nearly identical.  However, the alanine in LGM163 has been replaced with an ε-Boc-protected 
lysine in LGM235. 
Figure 4.2:  Structural Similarities Between LGM174, LGM235, and LGM163.
Currently, the mechanism by which these analogues perturb actin dynamics remains unclear.  However, 
these three analogues could be used as templates to expand this new class of natural-product analogues. 
Furthermore, structural studies might reveal important information about how these analogues interact 
with actin.
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Interestingly, although LGM235 was observed to induce perinuclear accumulation of actin over a broad 
range of concentrations (Fig. 3.3), this new phenotype was not observed during preliminary screening 
experiments of the fluorescently labeled analogues of LGM235 (data not shown).  Nevertheless, these 
analogues were capable of binding to actin in fixed and permeabilized cells8.  Furthermore, one of these 
fluorescently labeled analogues (21D) was found to be cell permeable and non-toxic, making it a useful 
new tool to study static, long-lived actin filaments in live N2a cells8.
4.2 Biosensors for Measuring Rho GTPase Activity
Rho GTPases are a group of signaling molecules that regulate various cellular processes, including 
rearrangement of the actin cytoskeleton (Fig. 1.5).  When a Rho GTPase is in the active (GTP-bound) 
state, it can interact with downstream effector proteins. Therefore, since effector proteins selectively 
bind to the active forms of Rho GTPases, they can be used as the basis for the design of Rho GTPase 
activity biosensors.
One of the simplest Rho GTPase activity biosensors consists of a fluorescent protein linked to the 
GTPase-binding domain (GBD) of an effector protein (Fig. 3.5A).  And, this type of biosensor was 
used for the work presented here.  There are multiple advantages to using this type of biosensor rather 
than FRET-based biosensors (Fig. 4.3).  First, each biosensor presented here is entirely encoded by a 
single plasmid.  However, for the approach shown in Figure 4.3A, two separate proteins must be 
overexpressed, each encoded by a separate plasmid.  Second, in the approach described here, each Rho 
GTPase activity is measured using a single fluorescent protein.  However, both of the approaches 
shown in Figure 4.3 require two fluorescent proteins to measure the activity of a single Rho GTPase.  
Third, the biosensors described here do not contain a prenylation site.  Therefore, they should not 
compete with endogenous Rho GTPases for binding to RhoGDI (Fig. 1.10d).  However, each of the 
approaches shown in Figure 4.3 would introduce a pool of prenylated proteins into the cell that would  
compete with endogenous Rho GTPases for binding to RhoGDI.  Finally, the biosensors described here 
can be used to measure the activities of endogenous proteins, while the approaches shown in Figure 4.3 
rely on activation of an overexpressed Rho GTPase.
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Initially, two published biosensors29, based on the PAK1 and WASP effector proteins were tested (Fig. 
3.8C).  However, only the WASP biosensor was recruited to the plasma membrane in response to 
photoactivation of Rac1.  Therefore, a new PAK1-based biosensor (delCMV-mCherry-PAK-GBD) was 
prepared.  There are two important features that distinguish the new PAK1-based biosensor from the 
previously published PAK1-based biosensor (Fig. 3.6).  First, the plasmid encoding the new biosensor 
has a delCMV promoter to ensure low-level expression of the protein.  Second, for the new biosensor, 
the fluorescent tag (mCherry) is fused to the N-terminus of the GBD, rather than the C-terminus.
A
B
Figure 4.3:  FRET-based Biosensors for Measuring Rho GTPase 
Activity.  (A) In this approach, a fluorescently labeled Rho GTPase and a 
fluorescently labeled binding domain from an effector protein (BD) are 
overexpressed in a cell.   If the fluorescently labeled Rho GTPase 
becomes activated, it can bind to the fluorescently labeled BD.  This 
binding is measured as an increase in FRET between the two fluorphores.  
(B) In this approach, a single fusion protein consisting of the BD, two 
fluorescent tags, and the Rho GTPase is overexpressed in a cell.  If the 
Rho GTPase becomes activated, it can bind to the BD.  This binding is 
measured as in increase in FRET between the two fluorphores. (This 
figure was taken from reference 63).
Consistent with the data shown in Fig. 3.8C, the previously published biosensor showed only a weak 
response to photoactivation of Rac1. However, similar experiments with the new PAK1-based 
biosensor produced a broad range of values (Fig. 3.10C).  One possible explanation for this is that the 
original PAK1-based construct was overexpressed at such a high level that it functioned more as an
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inhibitor of Rac1 rather than a biosensor of Rac1 activity.  Indeed, cells expressing the original PAK1-
based biosensor produced fewer lamellipodia upon photoactivation of Rac1 than cells expressing the 
published WASP biosensor or a control biosensor.  Alternatively, it is possible that the position of the 
fluorescent tag in the original PAK1-based biosensor interferes with its ability to bind to active Rac1.  
Unfortunately, there are currently no structural data for the Rac1/PAK1 complex.  However, the 
structure of Cdc42 in complex with a fragment of the PAK1 GBD has been solved by NMR64.  And, 
based on this structure, it would appear that the mCherry fluorescent tag should be tolerated well at 
either the N-terminus or the C-terminus of the PAK1 GBD fragment (Fig. 4.4).
Figure 4.4:  NMR Structure of Cdc42 in Complex with a Fragment of the PAK1 GBD.  
(PDB Code 1E0A64).
Although the new PAK1-based biosensor was more effective than the original PAK1-based biosensor, 
neither of these sensors are able to distinguish between active Rac1 and Cdc42.  Therefore, a new 
Rac1-specific biosensor based on the GBD of p67phox was also prepared.  On average, this new p67phox-
based biosensor produced a larger relative % change than either the original PAK1-based biosensor or 
the new PAK1-based biosensor in response to photoactivation of Rac1 (Fig. 3.10A and Fig. 3.10B). 
Furthermore, two new RhoA biosensors, both based on the GBD of the rhotekin effector protein were 
also prepared.
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Originally all of the biosensors were labeled with mCherry.  However, mCitrine versions of the 
optimized Rac1, Cdc42, and RhoA biosensors have also been prepared.  Therefore, two of these 
biosensors (one labeled with mCherry and the other labeled with mCitrine) could be used to 
simultaneously measure the activities of two distinct Rho GTPases in a single cell.  These biosensors 
could also be used in combination with blue and cyan fluorescent proteins, such as those described here 
for reversible recruitment of constitutively active Rho GTPases to the plasma membrane (Fig. 3.20B).  
Alternatively, these biosensors could be used in combination with optogenetic approaches that use 
wavelengths of light that fall outside the ranges used to excite mCitrine and mCherry.
4.3 Optogenetic Approaches to Controlling Rho GTPase Activity
Various methods have been proposed to control Rho GTPase activity in living cells.  For example, the 
extracellular growth factor lysophosphatidic acid can be added to cells in order to activate RhoA3.  
Alternatively, the bacterial toxin C3 transferase could be microinjected into a cell in order to inactivate 
RhoA65.  Microinjection can also be used to introduce the GEF FGD1 into a cell, which selectively 
activates Cdc423.  However, each of these methods suffers from certain limitations.  For example, in 
addition to activating RhoA, lysophosphatidic acid also activates other signaling pathways66.  Similarly, 
bacterial toxins may affect the activities of multiple Rho GTPases67.  Moreover, microinjection inflicts 
mechanical stress on cells that can affect their behavior.  In fact, a recent study specifically examined 
rearrangements in the actin cytoskeleton that were induced by puncturing a cell with a  microinjection 
needle68.  Therefore, recently published optogenetic tools to control Rho GTPase activity using light 
present attractive alternatives to previous activation methods.  One such tool is the photoactivatable 
Rac1 (PA-Rac1) construct described here.
PA-Rac1 is a fusion protein consisting of the LOV2 domain from Avena sativa (oat) phototropin1 
linked to the N-terminus of a constitutively active Rac1 mutant (Fig. 3.7A)35.  In the dark, the LOV2 
domain “cages” the Rac1 mutant and prevents it from interacting with downstream effector proteins 
(Fig. 3.7A).  However, when PA-Rac1 is exposed to light of an appropriate wavelength, the LOV2 
domain undergoes structural rearrangements that “uncage” the Rac1 mutant (Fig. 3.7A).
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This approach to controlling Rac1 activity has many attractive features.  First, because PA-Rac1 is 
encoded by a single plasmid, this approach is relatively simple to implement.  Also, photoactivation of 
Rac1 is rapid and reversible (Fig. 3.8B).  Furthermore, the amount of light required to activate PA-Rac1 
is extremely small (Fig. 3.9C).  Finally, PA-Rac1 could potentially be locally activated by restricting 
illumination to a selected region of the cell35.
In the TIRF setup described here, the positions of the light sources are relatively fixed.  However, this 
setup contains a motorized stage that can be used to control the positions of the cells.  Therefore, 
attempts to locally activate PA-Rac1 by positioning a cell in such a way that part of the cell would be 
illuminated while the rest of the cell would not were made (Fig. 4.5A).  However, in these experiments, 
Rac1 activity was observed to increase throughout the entire cell upon illumination (data not shown).  
Although an explanation for these results remains elusive, it is possible that the abnormal localization 
of PA-Rac1 (Fig. 3.14) may play a role.  Therefore, these experiments should be repeated with the 
optimized PA-Rac1 construct, which localizes primarily to the plasma membrane (Fig. 3.15).  
Furthermore, it should be noted that these experiments were done before the reversible photoactivation 
protocol was optimized.  Consequently, the amount of light used in these experiments far exceeded that 
which is necessary to maximally activate PA-Rac1.  Therefore, these experiments should be repeated 
using the optimized photoactivation protocol.
A B
Figure 4.5:  Local Activation of PA-Rac1.  (A) In this approach, the cell is 
positioned in such a way that part of the cell is illuminated while the rest of the cell 
is not.  (B) In this approach, laser light is focused to a small region of the cell.
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Recent modifications to the TIRF setup described here included the installation of a new TIRF 
condensor.  With this new condensor, it is possible to focus one laser to a small spot while using the 
remaining lasers for TIRF microscopy.  Although this feature was designed for use in Fluorescence 
Recovery After Photobleaching (FRAP) experiments, it could also be used to locally photoactivate 
Rac1 (Fig. 4.5B).  Another recent modification to the TIRF setup described here was the installation of 
a 445 nm laser.  Although the primary function of this laser is to excite cyan fluorescent proteins, the 
evanescent wave produced by this laser could also be used to selectively excite PA-Rac1 within a 
limited distance of the glass substrate (Fig. 1.15B).  And, both of these methods of locally activating 
PA-Rac1 are currently being explored using the original PA-Rac1 construct and the optimized PA-Rac1 
construct.  
Despite the many attractive features of PA-Rac1, it is also important to consider other optogenetic 
approaches to activate Rho GTPases in living cells. For example, Zhou et al. reported a new strategy to 
cage a protein that is based on the observation that two mutants of the fluorescent protein Dronpa 
(Dronpa145K and Dronpa 145N) heterodimerize upon illumination with light of one wavelength (~390 
nm) and dissociate upon illumination with light of another wavelength (~490 nm) (Fig. 4.6A)69.
A B
Figure 4.6:  Using Light Induced Heterodimerization to Cage a Protein of Interest.  (A)  
Cartoon illustrating the concept behind the new caging approach described by Zhou et al.69.  (B) 
Images of an NIH3T3 cell before (left) and after (right) uncaging of the Dbl homology domain 
of intersectin.  (These images were taken from reference 69).
Zhou et al. expressed a fusion protein (K-I-N-CAAX) containing the Dronpa145K mutant (K), the 
catalytic Dbl homology domain of a GEF called intersectin (I), the Dronpa145N mutant (N), and the 
CAAX box of K-Ras (CAAX) in NIH3T3 cells.  As expected, this protein localized primarily to the 
plasma membrane.  Furthermore, uncaging of the Dbl homology domain of intersectin led to the 
formation of filopodia (Fig. 4.6B)69, a phenotype commonly associated with activation of Cdc42 (Fig. 
1.5).
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The approach described by Zhou et al. shares many of the attractive features of PA-Rac1.  For example, 
K-I-N-CAAX is entirely encoded by a single plasmid.  Furthermore, localized illumination can be used 
to selectively uncage the Dbl homology domain of intersectin in a particular region of the cell.  And, 
filopodia formation induced by uncaging of this domain appears to be reversible69.  An additional 
attractive feature of this approach is that it can be used to activate endogenous Rho GTPases.  
However, because this method uses a GEF to activate a Rho GTPase, the effects of this activation 
might be delayed in comparison to direct light-based uncaging of PA-Rac1.  For example, although 
lamellipodia were frequently observed within five minutes of photoactivation of Rac1 (Fig. 3.7C), 
filopodia formation in response to uncaging of the Dbl homology domain of intersectin may require up 
to 30 minutes (Fig. 4.6B)69.
In contrast to the approach described by Zhou et al., where light-induced heterdimerization is used to 
cage a protein of interest, other optogenetic approaches use light-induced heterdimerization to target a 
protein of interest to the plasma membrane (Fig. 4.7)29,70.  In these approaches, one protein module 
(e.g., PhyB or CIBN) is tethered to the plasma membrane while another protein module (e.g., PIF6 or 
CRY2) is found predominantly in the cytosol.  And, light is used to induce heterodimerization and 
colocalization of these two protein modules at the plasma membrane.
A
B
Figure 4.7:  Using Light Induced Heterodimerization to Recruit a Protein of Interest to the 
Plasma Membrane.  (A) Cartoon illustrating the concept behind the recruitment approach 
described by Levskaya et al.29.  (B)  Cartoon illustrating the concept behind the recruitment 
approach described by Kennedy et al.70.  (These images were taken from references 29 and 70).
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Unlike the caging strategies described above, where a single protein is used to control Rho GTPase 
activity, the recruitment approaches shown in Figure 4.7 require two proteins to control the activity of a 
single Rho GTPase.  This makes the recruitment approaches shown in Figure 4.7 more difficult to 
implement than the caging strategies.  Furthermore, because plasma membrane recruitment is 
monitored using two fluorescent tags, these tags cannot be used to monitor other cellular processes.
Another significant disadvantage to the approach shown in Figure 4.7A is that it requires the addition 
of a cofactor called phycocyanobilin (PCB).  And, isolation of PCB from natural sources can be 
difficult and time-consuming.  Moreover, it should be noted that attempts to reproduce the results 
described by Levskaya et al. were only partially successful.  In particular, the catalytic domains of three 
different GEFs were rapidly targeted to the plasma membranes of N2a and NIH3T3 cells with this 
approach.  However, activation of Rho GTPases in response to this recruitment was not observed (data 
not shown).  It is also interesting to note that Levskaya et al. claimed that actin-based protrusions were 
observed within 5-10 minutes of light-induced heterodimerization29 while Kennedy et al. reported that 
their approach required up to 30 minutes to produce similar results (Fig. 4.6B)70.  This is somewhat
surprising, given that Levskaya et al. used light-induced heterodimerization to recruit a catalytic GEF 
domain to the plasma membrane (Fig. 4.7A) while Kennedy et al. used light to uncage a catalytic GEF 
domain that was already localized to the plasma membrane (Fig. 4.6A).
One major disadvantage shared by all of the optogenetic approaches described here is that the proteins 
used in these experiments to control Rho GTPase activity absorb light over a broad range of 
wavelengths, including those commonly used to excite many fluorescent proteins (Fig. 4.8).  Therefore, 
these approaches cannot be easily combined with other approaches that use fluorescent proteins to 
study cellular processes.
In summary, the subtle advantages and disadvantages associated with each of the optogenetic 
approaches described here can make it difficult to determine which of these approaches is best suited to 
study a particular cellular process.  Nevertheless, as a whole, these approaches represent an expanding 
set of tools that use light to control Rho GTPase activity in living cells.
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A B
C D
Figure 4.8:  Optogenetic Proteins Absorb Light Over Broad Ranges of Wavelengths.  
(A) Absorption spectrum of the LOV2 domain used in PA-Rac1.  (This figure was taken from 
reference 58).  (B)  Absorption spectra showing the range of wavelengths that regulate 
heterodimerization and dissociation of Dronpa145K and Dronpa145N.  (This figure was 
taken from reference 69).  (C) Graph showing the range of wavelengths that were observed to 
induced heterodimerization of PhyB and PIF6.  (This figure was taken from reference 29).  
(D) Absorption spectra of CRY2 before (black curve) and after exposure to various durations 
of blue light (red curve = 5 minutes, yellow curve = 10 minutes, green curve = 25 minutes, 
and blue curve = 30 minutes).  (This figure was taken from reference 71).
4.4 Using CID to Control Rho GTPase Activity
The Chemically Induced Dimerization (CID) system described here can be used to target a protein of 
interest to the plasma membrane (Fig. 3.16D).  This approach is similar to those shown in Figure 4.7.  
However, instead of using light to induce heterodimerization, a small molecule (referred to as a 
“dimerizer”) is used.  This approach also shares some of the same limitations as the light-based 
recruitment systems described above.  In particular, this approach requires two proteins to control the 
activity of a single Rho GTPase. Furthermore, because plasma membrane recruitment is monitored 
using two fluorescent tags, these tags cannot be used to monitor other cellular processes.
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However, one important advantage to using small molecules to control reversible heterodimerization 
(Fig. 3.16D) is that this approach can be easily combined with other approaches that use fluorescently 
labeled proteins.  For example, the mCherry and mCitrine biosensors described here can be used to 
simultaneously monitor how the activities of two Rho GTPases respond to reversible recruitment of a 
constitutively active Rho GTPase to the plasma membrane (Fig. 3.20B).  This makes it possible to 
directly study the crosstalk between these Rho GTPases within a single cell.  However, it is not 
possible to directly measure this crosstalk with the optogenetic approaches described above because 
these approaches do not directly measure to what extent the activity of a Rho GTPase changes in 
response to illumination.  For example, when a catalytic GEF domain is uncaged or recruited to the 
plasma membrane, it is not immediately clear how much of the corresponding endogenous Rho 
GTPase is activated in response to these perturbations.
Furthermore, unlike some of the optogenetic approaches described above that were only successfully 
applied to one or two Rho GTPases69,35, the approach described here was successfully used to control 
the activities of all three of the most well-studied Rho GTPases (Rac1, Cdc42, and RhoA).  Moreover, 
the CID system developed here was observed to produced rapid and reversible changes in cell 
morphology and the actin cytoskeleton (Fig. 3.21).  However, similar results were not obtained using 
the approach described by Levskaya et al.29 (data not shown).
Nevertheless, despite the many advantages associated with the CID system described here, it does 
suffer from one key limitation.  Namely, it would be difficult to use this system to locally activate a 
Rho GTPase.  However, a recent study suggests that, by subjecting cells to a gradient of dimerizer, CID 
can be used to direct cell migration.  In this study, the rapamycin-based CID system was used to control 
the localization of a Rac1 specific GEF called TIAM1 in HeLa cells (Fig. 4.9A)72.  In these 
experiments, cells were observed to migrate towards the direction of the highest dimerizer 
concentration (Fig. 4.9B)72. However, in these experiments, cells did not begin to move until 
approximately 1-1.5 hours after the gradient was imposed72 .  Furthermore, it is possible that the 
continuous application of the gradient in these experiments can lead to saturation of all available 
rapamycin binding sites72 .
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A B
Figure 4.9:  Using a Gradient of Dimerizer to Direct Cell Migration.  (A) Cartoon 
illustrating the CID system used by Lin et al.72. (B) A HeLa cell expressing the proteins shown 
in (A) was subjected to a gradient of the dimerizer rapamycin.  Eventually, this cell began to 
migrate towards the direction of the highest dimerizer concentration.  (These images were taken 
from reference 72).
It should be noted that the CID system described here has two key advantages over the rapamycin-
based system.  First, because neither of the two protein modules used here are endogenous to 
mammalian cells, this approach represents a novel bioorthogonal CID system that can be used to 
control protein function in cells.  Second, with this system, heterodimerization can be quickly disrupted 
by the addition of an inhibitor (Fig. 3.16C).
It should also be noted that current efforts are being made to develop an artificial receptor73 based on 
one of the protein modules describe here.  Once this artificial receptor has been optimized, the 
approach described by Gandor et al.73 can be used to localize this module to specific regions of the 
plasma membrane.  This would make it possible to gain more precise spatial control over the CID-
based recruitment system presented here.
4.5 Future Studies
Here, both optogenetic and CID-based approaches were used to perturb Rho GTPase activity in living 
cells.  Furthermore, a series of biosensors was developed to measure Rho GTPase activity.  And, these 
tools were used to examine the crosstalk between Rac1, Cdc42, and RhoA in N2a cells.  Currently, 
these studies suggest that both Cdc42 and RhoA are activated in response to activation of Rac1. This 
was surprising, as mutual inhibition between RhoA and Rac1 is generally favored in the literature as a 
mechanism to segregate protrusive (Rac1-based) and contractile (RhoA-based) signals during cell 
polarization26. 
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Future studies will focus on using the tools developed here to identify proteins that play a key role in 
regulating the crosstalk between Rac1, Cdc42, and RhoA.  These studies will also investigate how 
crosstalk between these Rho GTPases is related to cellular morphogenesis in normal cell function and 
disease.
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